Interim / Quarterly Report • Jul 17, 2023
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
January-June 2023
"Investor performed strongly during the second quarter. Our subsidiaries within Patricia Industries reported double-digit organic sales growth and sharply rising profits. In the current complex environment with a continued uncertain macroeconomic outlook, ensuring high flexibility and the ability to respond swiftly to rapid changes remains imperative."
Johan Forssell, President & CEO of Investor
| Financial information* | ||||
|---|---|---|---|---|
| 6/30 2023 | 3/31 2023 | 12/31 2022 | ||
| Adjusted NAV, SEK m* | 773,060 | 723,621 | 673,250 | |
| Adjusted NAV, SEK per share* | 252 | 236 | 220 | |
| Reported NAV, SEK m*1) | 674,068 | 638,142 | 604,865 | |
| Reported NAV, SEK per share*1) | 220 | 208 | 197 | |
| Market capitalization (both share classes), excluding repurchased shares, SEK m | 660,496 | 637,575 | 584,163 | |
| Share price (B-share), SEK | 215.65 | 206.05 | 188.56 | |
| Q2 2023 | H1 2023 | |||
| Adjusted NAV, sequential change, incl. dividend added back, SEK m* | 62,916 | 113,288 | ||
| Adjusted NAV, sequential change, incl. dividend added back, %* | 9 | 17 | ||
| Reported NAV, sequential change, incl. dividend added back, SEK m*1) | 49,403 | 82,680 | ||
| Reported NAV, sequential change, incl. dividend added back, %*1) | 8 | 14 | ||
| Market capitalization, sequential change, incl. dividend added back, SEK m* | 33,030 | 86,441 | ||
| Market capitalization, sequential change, incl. dividend added back, %* | 5 | 15 | ||
| Q2 2023 | Q2 2022 | H1 2023 | H1 2022 | |
| Consolidated net sales, SEK m | 14,831 | 12,280 | 28,841 | 23,929 |
| Consolidated profit/loss, SEK m | 45,309 | -65,521 | 78,121 | -134,646 |
| Basic earnings per share, SEK | 14.80 | -21.38 | 25.53 | -43.93 |
* Financial measures that are not defined or specified in the applicable financial reporting framework. For more information, see page 18 and 31-32. Change in market capitalization with dividend added back reflects the change in total market capitalization with the dividend paid out added back. Change in net asset value with dividend added back includes the full dividend approved by the AGM.
1) In the reported net asset value, the wholly-owned subsidiaries and partner-owned investments within Patricia Industries are reported according to the acquisition and equity method respectively. Methods are further described in Investor AB's Annual Report.
| YTD | 1 year | 5 years | 10 years | 20 years | |
|---|---|---|---|---|---|
| Adjusted NAV incl. dividend added back, % | 16.8 | 28.8 | 16.5 | ||
| Investor B, total return, % | 16.1 | 30.9 | 21.5 | 20.0 | 17.7 |
| SIXRX return index, % | 11.3 | 19.3 | 11.3 | 12.3 | 12.4 |
Dear fellow shareholders,
In the second quarter we delivered the highest adjusted net asset value ever, and Patricia Industries' profit reached a new record level. Our adjusted net asset value growth and total shareholder return amounted to 9 and 6 percent respectively, both outperforming the SIXRX return index that gained 2 percent. Our subsidiaries within Patricia Industries reported double-digit
organic sales growth and sharply rising profits. Also, after a few weaker quarters, cash conversion returned to healthier levels.
The macro outlook remains uncertain. Lingering inflation, prompting central banks to further rate hikes, continues to weigh on consumers. The geopolitical situation is complex and in China, the pace of the post pandemic recovery adds further uncertainty. On a positive note, supply chain constraints continue to ease, and significant investments are made to capitalize on opportunities related to climate change and digitalization. We also see increased capex in certain industries due to the geopolitical situation and the need to increase resilience by investing more regionally. In this complex and fast moving environment, ensuring high flexibility and the ability to respond swiftly to rapid changes in demand remains imperative for our companies.
Listed Companies generated a total return of 9 percent during the quarter, primarily driven by Atlas Copco and ABB. Several of our companies took strategic actions to expand their customer offerings. Nasdaq expanded its position as a leading technology provider to the financial markets through the acquisition of Adenza. Through the acquisition of AirPlus, SEB will become a European leader within corporate payment solutions, and Sobi completed its acquisition of CTI Biopharma, broadening its product portfolio within hematology. As communicated, we will subscribe for our pro rata share in the rights issue that will partly finance the transaction.
We divested nearly 30 percent of our holding in the Swiss company Accelleron, spun off from ABB, for total proceeds of approximately SEK 1bn.
Based on estimated market values, Patricia Industries' total return, excluding cash, amounted to 11 percent during the quarter, mainly driven by strong earnings growth, followed by positive currency impact. Multiple expansion and cash flow also impacted positively, but to a lesser extent. Sales growth for the major subsidiaries amounted to 22 percent, of which 13 percent organic in constant currency. Adjusted EBITA growth was strong at 34 percent. Looking into the second half of 2023, it is worth remembering that the third quarter 2022 was strong, while the fourth quarter was relatively weaker. This will impact the year-over-year comparison for these two quarters.
Mölnlycke reported organic sales growth of 6 percent in constant currency, driven by continued strong performance in Wound Care and Operating Room Solutions. The operating margin improved and cash conversion strengthened significantly compared to last year.
All other subsidiaries except for Advanced Instruments and Atlas Antibodies grew organically, led by BraunAbility, Sarnova and Permobil. Subdued demand from the biopharma segment continued to impact Atlas Antibodies and Advanced Instruments.
During the quarter, Vectura announced the divestment of its Community Service portfolio, primarily consisting of elderly care properties. This is in line with the company's new strategic focus on developing real estate for innovation clusters, which also offers synergies with several of our portfolio companies, including AstraZeneca and Mölnlycke. We are pleased that Vectura has found a great new home for these high-quality properties, realizing an annual return on investment of approximately 15 percent during its ownership.
The total return on Investments in EQT amounted to 3 percent during the second quarter, driven by our fund investments. Net cash flow to Investor amounted to SEK 0.5bn. In May, EQT launched Nexus, broadening its investor base by offering individuals access to its different investment strategies.
Our industry-leading companies, with strong profitability and cash flow generation, as well as high exposure to secular growth, form the basis for our long-term value creation. As an engaged owner, we continue to drive initiatives to ensure long-term competitiveness. Embracing new technology is clearly a strategic priority. Undoubtedly, AI will impact all businesses. Progress is rapid and our companies are launching many activities. We are currently running deep-dive analysis and education programs to gain improved understanding of the opportunities which AI brings in our prioritized industries and portfolio companies.
At the end of the quarter, our leverage was 2 percent, at the low end of our 0-10 percent target range. In combination with our strong cash flow generation, this provides us with significant financial capacity to support our companies and invest in all three business areas, based on where we find the most value-creating opportunities.
With our well-proven business model, strong portfolio of companies, clear strategic direction and financial strength, I remain confident in our ability to continue to grow net asset value. This is what ultimately will drive attractive total returns to you, dear fellow shareholders.
Johan Forssell President & CEO
| Adjusted values | Reported values | ||||||
|---|---|---|---|---|---|---|---|
| Number of | Ownership | Share of total | Value, | Value, | Value, | Value, | |
| shares | capital/votes (%) | assets (%) | SEK m | SEK m | SEK m | SEK m | |
| 6/30 2023 | 6/30 2023 | 6/30 2023 | 6/30 2023 | 12/31 2022 | 6/30 2023 | 12/31 2022 | |
| Listed Companies Atlas Copco |
835,653,755 | 17.0/22.3 | 16 | 128,457 | 102,091 | 128,457 | 102,091 |
| ABB | 265,385,142 | 14.1/14.1 | 14 | 112,356 | 83,944 | 112,356 | 83,944 |
| AstraZeneca | 51,587,810 | 3.3/3.3 | 10 | 79,806 | 72,403 | 79,806 | 72,403 |
| SEB | 456,198,927 | 21.3/21.4 | 7 | 54,381 | 54,646 | 54,381 | 54,646 |
| Epiroc | 207,635,622 | 17.1/22.7 | 5 | 42,013 | 39,075 | 42,013 | 39,075 |
| Nasdaq | 58,182,426 | 11.9/11.9 | 4 | 31,459 | 37,249 | 31,459 | 37,249 |
| Saab | 40,972,622 | 30.2/39.7 | 3 | 23,862 | 16,852 | 23,862 | 16,852 |
| Sobi | 107,594,165 | 34.6/34.6 | 3 | 22,571 | 23,270 | 22,571 | 23,270 |
| Ericsson | 266,745,735 | 8.0/23.7 | 2 | 15,935 | 16,849 | 15,935 | 16,849 |
| Wärtsilä | 104,711,363 | 17.7/17.7 | 2 | 12,741 | 9,196 | 12,741 | 9,196 |
| Husqvarna | 97,052,157 | 16.8/33.4 | 1 | 9,456 | 7,122 | 9,456 | 7,122 |
| Electrolux | 50,786,412 | 17.9/30.4 | 1 | 7,477 | 7,151 | 7,477 | 7,151 |
| Electrolux Professional | 58,941,654 | 20.5/32.5 | 0 | 3,416 | 2,579 | 3,416 | 2,579 |
| Accelleron | 9,671,926 | 10.2/10.2 | 0 | 2,499 | 2,868 | 2,499 | 2,868 |
| Total Listed Companies | 69 | 546,431 | 475,296 | 546,431 | 475,296 | ||
| Patricia Industries | Total exposure (%) | ||||||
| Subsidiaries | |||||||
| Mölnlycke1) | 99 | 10 | 77,479 | 58,888 | 21,983 | 18,780 | |
| Laborie | 98 | 3 | 20,411 | 15,991 | 9,645 | 9,580 | |
| Sarnova | 95 | 2 | 16,142 | 12,674 | 8,333 | 8,029 | |
| Permobil1) | 98 | 2 | 15,206 | 11,651 | 4,937 | 5,211 | |
| Advanced Instruments | 98 | 1 | 10,957 | 10,073 | 8,893 | 8,575 | |
| Piab1) | 97 | 1 | 9,295 | 7,869 | 6,411 | 6,189 | |
| BraunAbility | 93 | 1 | 8,632 | 5,222 | 2,538 | 2,388 | |
| Vectura | 99 | 0 | 3,766 | 3,845 | 4,040 | 3,821 | |
| Atlas Antibodies | 93 | 0 | 2,898 | 2,807 | 3,084 | 2,853 | |
| Total subsidiaries | 21 | 164,785 | 129,019 | 69,863 | 65,424 | ||
| Three Scandinavia | 40/40 | 1 | 6,953 | 7,504 | 2,882 | 2,714 | |
| Financial Investments | 0 | 1,737 | 1,972 | 1,737 | 1,972 | ||
| Total Patricia Industries excl. cash | 22 | 173,475 | 138,495 | 74,482 | 70,110 | ||
| Total Patricia Industries incl. cash | 185,005 | 150,317 | 86,013 | 81,933 | |||
| Investments in EQT | |||||||
| EQT AB | 174,288,016 | 14.7/14.7 | 5 | 36,200 | 38,500 | 36,200 | 38,500 |
| Fund investments | 4 | 33,793 | 31,550 | 33,793 | 31,550 | ||
| Total Investments in EQT | 9 | 69,992 | 70,050 | 69,992 | 70,050 | ||
| Other Assets and Liabilities2) | 0 | -3,620 | -328 | -3,620 | -328 | ||
| Total Assets excl. cash Patricia Industries | 100 | 786,278 | 683,513 | 687,285 | 615,128 | ||
| Gross debt* | -40,708 | -38,796 | -40,708 | -38,796 | |||
| Gross cash* | 27,491 | 28,533 | 27,491 | 28,533 | |||
| Of which Patricia Industries | 11,530 | 11,823 | 11,530 | 11,823 | |||
| Net debt | -13,218 | -10,263 | -13,218 | -10,263 | |||
| Net Asset Value | 773,060 | 673,250 | 674,068 | 604,865 | |||
| Net Asset Value per share | 252 | 220 | 220 | 197 | |||
1) Including receivables related to Management Participation Program foundations. For Mölnlycke, the receivable corresponds to less than 1 percentage point of the total exposure, for Permobil to approximately 2 percentage points and for Piab to approximately 3 percentage points.
2) As per 6/30 2023, including liability for dividend to shareholders of SEK 3,369m to be paid in November 2023.
For balance sheet items, figures in parentheses refer to year-end 2022 figures. For income statement and cash flow items, they refer to the same period last year.
During the first half of 2023, adjusted net asset value increased from SEK 673.2bn to SEK 773.1bn. The change in adjusted net asset value, with dividend added back, was 17 percent during the period (-18), of which 9 percent during the second quarter (-9).
Reported net asset value increased from SEK 604.9bn to SEK 674.1bn. The change in reported net asset value, with dividend added back, was 14 percent during the period (-19), of which 8 percent during the second quarter (-10).
Total adjusted assets by business area
Net debt totaled SEK 13,218m on June 30, 2023 (10,263), corresponding to leverage of 1.7 percent (1.5).
Our target leverage range is 0-10 percent (net debt/total adjusted assets) over a business cycle. While leverage can fluctuate above and below the target level, it should not exceed 20 percent for a longer period of time.
Gross cash amounted to SEK 27,491m and gross debt to SEK 40,708m as of June 30, 2023. The average maturity of Investor AB's debt portfolio was 11.3 years on June 30, 2023 (11.8).
| SEK m | H1 2023 |
|---|---|
| Opening net debt | -10,263 |
| Listed Companies | |
| Dividends | 9,165 |
| Divestments | 914 |
| Other capital distributions | 46 |
| Investments, net of proceeds | -1 |
| Management cost | -79 |
| Total | 10,045 |
| Patricia Industries | |
| Proceeds | 465 |
| Investments | -742 |
| Management cost | -157 |
| Other1) | 142 |
| Total | -292 |
| Investments in EQT | |
| Proceeds (divestitures, fee surplus and carry) | 2,438 |
| Drawdowns (investments and management fees) | -2,304 |
| Management cost | -5 |
| Total | 128 |
| Investor groupwide | |
| Dividend to shareholders | -10,109 |
| Management cost | -74 |
| Other2) | -2,654 |
| Closing net debt | -13,218 |
1) Incl. currency related effects and net interest paid.
2) Incl. currency related effects, revaluation of debt and net interest paid.
Investor's management cost amounted to SEK 316m during the first half of 2023 (285), of which SEK 162m during the second quarter (152).
As of June 30, 2023, rolling 12-month management cost amounted to 0.08 percent of the adjusted net asset value.
The price of the Investor A-share and B-share was SEK 215.70 and SEK 215.65 respectively on June 30, 2023, compared to SEK 193.85 and SEK 188.56 on December 31, 2022.
The total shareholder return (Class B-share) amounted to 16 percent during the first half of 2023 (-25), of which 6 percent during the second quarter (-17).
The SIXRX return index was 11 percent during the first half of 2023 (-28), of which 2 percent during the second quarter (-16).
Investor's market capitalization, excluding repurchased shares, was SEK 660,496m as of June 30, 2023 (584,163).
Listed Companies include ABB, Accelleron, AstraZeneca, Atlas Copco, Electrolux, Electrolux Professional, Epiroc, Ericsson, Husqvarna, Nasdaq, Saab, SEB, Sobi and Wärtsilä. These are multinational companies with strong market positions and proven track records.
Total return (excluding management costs) amounted to 17 percent during the first half of 2023, of which 9 percent during the second quarter.
The SIXRX return index was 11 percent during the first half of 2023, of which 2 percent during the second quarter.
Contribution to net asset value (adjusted and reported) amounted to SEK 81,209m during the first half of 2023 (-88,076), of which SEK 45,649m during the second quarter (-36,822).
| Total | 45,649 | 81,209 | -88,076 |
|---|---|---|---|
| Management cost | -40 | -79 | -69 |
| Dividends | 4,953 | 9,165 | 8,207 |
| Changes in value | 40,736 | 72,123 | -96,214 |
| Q2 2023 | H1 2023 | ||||
|---|---|---|---|---|---|
| Value, SEK m |
Contribution, SEK m |
Total return (%)1) |
Contribution, SEK m |
Total return (%)1) |
|
| Atlas Copco | 128,457 | 19,895 | 18.2 | 27,361 | 26.8 |
| ABB | 112,356 | 17,907 | 19.0 | 30,925 | 37.6 |
| AstraZeneca | 79,806 | 5,314 | 7.1 | 8,470 | 11.8 |
| SEB | 54,381 | 5,131 | 10.5 | 2,814 | 5.8 |
| Epiroc | 42,013 | -182 | -0.4 | 3,304 | 8.5 |
| Nasdaq | 31,459 | -1,332 | -4.1 | -5,542 | -14.9 |
| Saab | 23,862 | -1,791 | -7.0 | 7,228 | 42.8 |
| Sobi | 22,571 | -3,377 | -13.0 | -699 | -3.0 |
| Ericsson | 15,935 | -870 | -5.2 | -554 | -3.4 |
| Wärtsilä | 12,741 | 2,490 | 24.3 | 3,699 | 40.7 |
| Husqvarna | 9,456 | 858 | 10.0 | 2,431 | 34.3 |
| Electrolux | 7,477 | 1,104 | 17.3 | 326 | 4.6 |
| Electrolux Professional |
3,416 | 276 | 8.7 | 878 | 34.1 |
| Accelleron | 2,499 | 266 | 8.1 | 646 | 22.5 |
| Total | 546,431 | 45,689 | 9.1 | 81,288 | 17.4 |
1) Calculated as the sum of share price changes with reinvested dividends, including add-on investments and/or divestments.
Dividends received totaled SEK 9,165m during the first half of 2023 (8,207), of which SEK 4,953m during the second quarter (1,537).
During the second quarter 2023 3,597,331 Accelleron shares were sold for SEK 943m. Atlas Copco's chairperson exercised all options, sold by Investor in 2019, and bought 477,380 A-shares for a consideration of SEK 39m. New 5-year options, with a strike price of 110 percent of the share price, were sold to the chairperson in Atlas Copco for a total consideration of SEK 5m.
During the first quarter 2023, Epiroc's chairperson exercised all options, sold by Investor in 2019, and bought shares for a consideration of SEK 15m. New 5-year options, with a strike price of 110 percent of the share price, were sold to the chairperson in Epiroc for a total consideration of SEK 2m.
Patricia Industries develops wholly-owned companies in the Nordics and in North America. Holdings include Advanced Instruments, Atlas Antibodies, BraunAbility, Laborie, Mölnlycke, Permobil, Piab, Sarnova, Vectura, Three Scandinavia and Financial Investments.
During the first half of 2023, sales growth for the major subsidiaries was 22 percent. Organic growth was 12 percent in constant currency. EBITA amounted to SEK 5,707m, an increase of 37 percent. Adjusting for items affecting comparability, EBITA grew by 34 percent.
During the second quarter 2023, sales growth amounted to 22 percent. Organic growth was 13 percent in constant currency. EBITA amounted to SEK 2,982m, an increase of 40 percent. Adjusted EBITA grew by 34 percent.
As of June 30, 2023, on a rolling 12-month basis, the companies' (subsidiaries and 40 percent of Three Scandinavia) combined sales and EBITDA amounted to SEK 59.6bn and SEK 14.0bn respectively. The corresponding figures as of March 31, 2023 were SEK 56.9bn and SEK 13.0bn respectively. During the second quarter 2023, sales and EBITDA amounted to SEK 15.6bn (12.9), and SEK 3.8bn (2.9) respectively.
Reported EBITDA (subsidiaries & 40% of Three Scandinavia)
| Org. growth, constant |
Operating | ||||||
|---|---|---|---|---|---|---|---|
| SEK m | Sales | currency | EBITDA | EBITDA (%) | EBITA1) | EBITA, (%) | cash flow |
| Mölnlycke | 5,442 | 6 | 1,546 | 28.4 | 1,362 | 25.0 | 1,275 |
| Laborie | 939 | 2 | 308 | 32.8 | 292 | 31.1 | 123 |
| Sarnova | 2,600 | 17 | 420 | 16.2 | 369 | 14.2 | 383 |
| Permobil | 1,407 | 13 | 281 | 20.0 | 230 | 16.3 | 201 |
| Advanced Instruments | 393 | -1 | 168 | 42.7 | 160 | 40.7 | 164 |
| Piab | 789 | 4 | 222 | 28.2 | 193 | 24.5 | 199 |
| BraunAbility | 3,025 | 36 | 390 | 12.9 | 337 | 11.1 | 248 |
| Vectura | 82 | 9 | 41 | 49.5 | 4 | 4.7 | -347 |
| Atlas Antibodies | 108 | -6 | 43 | 40.0 | 36 | 32.9 | 36 |
| Total | 14,785 | 3,418 | 23.1 | 2,982 | 20.2 | 2,281 | |
| Reported growth y/y, % | 22 | 36 | 40 | ||||
| Organic growth, y/y, % | 13 |
H1 2023
| Org. growth, constant |
Operating | ||||||
|---|---|---|---|---|---|---|---|
| SEK m | Sales | currency | EBITDA | EBITDA (%) | EBITA1) | EBITA, (%) | cash flow |
| Mölnlycke | 10,810 | 9 | 3,065 | 28.4 | 2,702 | 25.0 | 1,880 |
| Laborie | 1,812 | 5 | 564 | 31.1 | 532 | 29.3 | 358 |
| Sarnova | 5,148 | 14 | 770 | 15.0 | 670 | 13.0 | 822 |
| Permobil | 2,720 | 11 | 517 | 19.0 | 414 | 15.2 | 379 |
| Advanced Instruments | 745 | -5 | 294 | 39.5 | 280 | 37.5 | 238 |
| Piab | 1,509 | 8 | 428 | 28.3 | 374 | 24.8 | 314 |
| BraunAbility | 5,634 | 23 | 732 | 13.0 | 626 | 11.1 | 251 |
| Vectura | 166 | 11 | 96 | 57.7 | 27 | 16.4 | -699 |
| Atlas Antibodies | 219 | 1 | 97 | 44.3 | 82 | 37.4 | 64 |
| Total | 28,762 | 6,563 | 22.8 | 5,707 | 19.8 | 3,607 | |
| Reported growth y/y, % | 22 | 34 | 37 | ||||
| Organic growth, y/y, % | 12 |
1) EBITA is defined as operating profit before acquisition-related amortizations.
Contribution to adjusted net asset value amounted to SEK 34,538m during the first half of 2023 (-4,829), of which SEK 16,671m during the second quarter (2,468).
| SEK m | Q2 2023 | H1 2023 | H1 2022 |
|---|---|---|---|
| Changes in value | 16,761 | 34,704 | -4,686 |
| Management cost | -80 | -157 | -149 |
| Other | -10 | -9 | 6 |
| Total | 16,671 | 34,538 | -4,829 |
Based on estimated market values, the total return for Patricia Industries, excluding cash, amounted to 25 percent (23 percent including cash) during the first half of 2023, of which 11 percent (10 percent including cash) during the second quarter. The positive return during the second quarter was mainly driven by strong earnings growth, followed by positive currency impact. Multiple expansion and cash flow also impacted positively, but to a lesser extent.
For more information on valuation, see page 35.
During the first half of 2023, investments amounted to SEK 742m, of which SEK 508m during the second quarter, mainly relating to Vectura.
Divestments amounted to SEK 70m during the the first half of 2023, of which SEK 5m during the second quarter.
During the first half of 2023, distributions to Patricia Industries amounted to SEK 395m (mainly related to distribution from Permobil), of which SEK 2m during the second quarter.
| SEK m | Q2 2023 | H1 2023 | H1 2022 |
|---|---|---|---|
| Beginning of period | 12,017 | 11,823 | 12,505 |
| Net cash flow | -501 | -277 | -1,937 |
| Internal transfer to Investor | - | - | -3,124 |
| Other1) | 14 | -16 | -105 |
| End of period | 11,530 | 11,530 | 7,340 |
1) Includes currency-related effects, net interest and management cost.
| Patricia Industries – valuation overview | ||||
|---|---|---|---|---|
| Estimated market values, SEK m, 6/30, 2023 |
Change Q2 2023 vs. Q1 2023 SEK m |
Major drivers | Comments | |
| Subsidiaries | ||||
| Mölnlycke | 77,479 | 8,838 | Currency, multiples, earnings and cash flow impacted positively |
Applied EV/reported LTM EBITDA 15.9x |
| Laborie | 20,411 | 1,636 | Currency and earnings impacted positively |
Applied EV/adjusted LTM EBITDA 19.0x |
| Sarnova | 16,142 | 2,502 | Earnings and currency impacted positively |
Applied EV/adjusted LTM EBITDA 14.3x |
| Permobil | 15,206 | 1,782 | Earnings and multiples impacted positively |
Applied EV/reported LTM EBITDA 15.8x |
| Advanced Instruments | 10,957 | 218 | Currency impacted positively, multiples impacted negatively |
Applied EV/adjusted LTM EBITDA 19.5x. Acquisitions of Solentim and Artel valued at cost |
| Piab | 9,295 | 8 | Earnings impacted positively, multiples impacted negatively |
Applied EV/adjusted LTM EBITDA 15.8x |
| BraunAbility | 8,632 | 2,228 | Earnings impacted positively | Applied EV/adjusted LTM EBITDA 10.5x |
| Vectura | 3,766 | 14 | SEK 0.4bn contribution from Patricia Industries, value impacted by taxes and transaction costs related to the divestment of elderly care properties |
Estimated market value of the property portfolio less debt and cost |
| Atlas Antibodies | 2,898 | -30 | No major drivers | Applied EV/adjusted LTM EBITDA 17.6x |
| Partner-owned investments |
||||
| Three Scandinavia | 6,953 | 171 | Earnings impacted positively | Applied EV/adjusted LTM EBITDA 6.3x |
| Financial Investments | 1,737 | -106 | Multiple or third-party valuation, share price | |
| Total | 173,475 | |||
| Total incl. cash | 185,005 |
A provider of single-use products and solutions for managing wounds, improving surgical safety and efficiency, and preventing pressure ulcers. Read more at www.molnlycke.com
• Organic sales growth amounted to 10 percent in constant currency, benefitting from increased elective surgery activity, price increases and improved product mix. From a product perspective, growth was mainly driven by Trays.
• Organic sales growth amounted to -6 percent in constant currency. The decline was mainly related to the US market where distributors are reducing excess inventory built up during second half of 2022.
• Organic sales growth amounted to -5 percent in constant currency. The US showed stable growth, while supply chain challenges remain in EMEA.
| 2023 | 2022 | ||||
|---|---|---|---|---|---|
| Income statement items, EUR m |
Q2 | H1 | Q2 | H1 | Last 12 months |
| Sales | 475 | 955 | 459 | 885 | 1,898 |
| EBITDA | 135 | 271 | 125 | 237 | 510 |
| EBITA | 119 | 239 | 108 | 204 | 445 |
| Sales growth, % | 4 | 8 | 10 | 3 | |
| Organic growth, constant currency, % |
6 | 9 | 5 | -1 | |
| EBITDA, % | 28.4 | 28.4 | 27.2 | 26.8 | 26.9 |
| EBITA, % | 25.0 | 25.0 | 23.6 | 23.1 | 23.4 |
| Cash flow items, EUR m | Q2 | H1 | Q2 | H1 | |
| EBITDA | 135 | 271 | 125 | 237 | |
| Lease payments | -6 | -12 | -5 | -11 | |
| Change in working capital | -7 | -71 | -30 | -95 | |
| Capital expenditures | -10 | -22 | -18 | -30 | |
| Operating cash flow | 112 | 166 | 73 | 101 | |
| Acquisitions/divestments | - | 0 | - | - | |
| Shareholder contribution/distribution |
- | - | - | - | |
| Other1) | -20 | -36 | -28 | -68 | |
| Increase(-)/decrease(+) in net debt |
92 | 129 | 44 | 33 | |
| Key ratios | |||||
| Working capital/sales, % | 19 | ||||
| Capital expenditures/sales, % | 3 | ||||
| Balance sheet items, EUR m | 6/30 2023 | 12/31 2022 | |||
| Net debt | 1,492 | 1,621 | |||
| 6/30 2023 | 6/30 2022 | ||||
| Number of employees | 8,705 | 8,625 | |||
| 1) Includes effects of exchange rate changes, interest, tax and change in lease |
liabilities.
| Share of sales, (%) Last 12 months |
Organic growth, constant currency, (%) Q2 2023 |
|
|---|---|---|
| Wound Care | 58 | 8 |
| Operating Room Solutions |
25 | 10 |
| Gloves | 13 | -6 |
| Antiseptics | 3 | -5 |
| Total | 100 | 6 |
| Share of sales, (%) 2022 |
|
|---|---|
| Europe, Middle East, Africa | 56 |
| Americas | 35 |
| Asia Pacific | 9 |
| Total | 100 |
A provider of diagnostic and therapeutic products within Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal. Read more at www.laborie.com
| Income statement items, | 2023 | 2022 | Last 12 | ||
|---|---|---|---|---|---|
| USD m | Q2 | H1 | Q2 | H1 | months |
| Sales | 89 | 173 | 87 | 166 | 346 |
| EBITDA | 29 | 54 | 23 | 42 | 109 |
| EBITA | 28 | 51 | 22 | 38 | 103 |
| Sales growth, % | 2 | 4 | 9 | 6 | |
| Organic growth, | 2 | 5 | 9 | 7 | |
| constant currency, % | |||||
| EBITDA, % | 32.8 | 31.1 | 26.8 | 25.1 | 31.6 |
| EBITA, % | 31.1 | 29.3 | 25.0 | 23.1 | 29.7 |
| Cash flow items, USD m | Q2 | H1 | Q2 | H1 | |
| EBITDA | 29 | 54 | 23 | 42 | |
| Lease payments | -1 | -1 | -1 | -1 | |
| Change in working capital | -14 | -13 | -8 | -23 | |
| Capital expenditures | -3 | -6 | -2 | -3 | |
| Operating cash flow | 12 | 34 | 13 | 15 | |
| Acquisitions/divestments | - | -3 | -27 | -167 | |
| Shareholder | - | - | - | 100 | |
| contribution/distribution | |||||
| Other1) | -6 | -16 | -6 | 2 | |
| Increase(-)/decrease(+) in net debt |
5 | 15 | -20 | -51 | |
| Key ratios | |||||
| Working capital/sales, % | 21 | ||||
| Capital expenditures/sales, % | 3 | ||||
| Balance sheet items, USD m | 6/30 2023 | 12/31 2022 | |||
| Net debt | 439 | 454 | |||
| 6/30 2023 | 6/30 2022 | ||||
| Number of employees | 905 | 885 | |||
1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.
A US provider of specialty healthcare and safety products, services and software for the US emergency medical services (EMS), acute care and cardiac response markets. Read more at www.sarnova.com
| Income statement items, | 2023 | 2022 | Last 12 | ||
|---|---|---|---|---|---|
| USD m | Q2 | H1 | Q2 | H1 | months |
| Sales | 247 | 492 | 211 | 432 | 976 |
| EBITDA | 40 | 74 | 28 | 59 | 150 |
| EBITA | 35 | 64 | 24 | 50 | 132 |
| Sales growth, % | 17 | 14 | 15 | 16 | |
| Organic growth, constant currency, % |
17 | 14 | 6 | 4 | |
| EBITDA, % | 16.2 | 15.0 | 13.4 | 13.5 | 15.4 |
| EBITA, % | 14.2 | 13.0 | 11.5 | 11.6 | 13.5 |
| Cash flow items, USD m | Q2 | H1 | Q2 | H1 | |
| EBITDA | 40 | 74 | 28 | 59 | |
| Lease payments | -1 | -2 | -1 | -2 | |
| Change in working capital | 1 | 14 | 0 | 12 | |
| Capital expenditures | -4 | -7 | -7 | -11 | |
| Operating cash flow | 36 | 78 | 20 | 58 | |
| Acquisitions/divestments | - | - | - | - | |
| Shareholder | - | - | - | - | |
| contribution/distribution | |||||
| Other1) | -20 | -32 | -20 | -27 | |
| Increase(-)/decrease(+) in net debt |
16 | 46 | 0 | 31 | |
| Key ratios | |||||
| Working capital/sales, % | 14 | ||||
| Capital expenditures/sales, % | 1 | ||||
| Balance sheet items, USD m | 6/30 2023 | 12/31 2022 | |||
| Net debt | 480 | 526 | |||
| 6/30 2023 | 6/30 2022 | ||||
| Number of employees | 1,405 | 1,360 | |||
A provider of advanced mobility and seating rehab solutions, including powered and manual wheelchairs, pressure-relieving cushions and powerassist devices. Read more at www.permobil.com
| Income statement items, | 2023 | 2022 | Last 12 | ||
|---|---|---|---|---|---|
| SEK m | Q2 | H1 | Q2 | H1 | months |
| Sales | 1,407 2,720 1,177 2,293 | 5,676 | |||
| EBITDA | 281 | 517 | 187 | 364 | 1,223 |
| EBITA | 230 | 414 | 145 | 278 | 1,016 |
| Sales growth, % | 20 | 19 | 20 | 21 | |
| Organic growth, | 13 | 11 | 0 | 3 | |
| constant currency, % | |||||
| EBITDA, % | 20.0 | 19.0 | 15.9 | 15.9 | 21.5 |
| EBITA, % | 16.3 | 15.2 | 12.3 | 12.1 | 17.9 |
| Cash flow items, SEK m | Q2 | H1 | Q2 | H1 | |
| EBITDA | 281 | 517 | 187 | 364 | |
| Lease payments | -20 | -40 | -15 | -31 | |
| Change in working capital | 12 | 42 | -49 | -169 | |
| Capital expenditures | -72 | -141 | -110 | -164 | |
| Operating cash flow | 201 | 379 | 13 | 0 | |
| Acquisitions/divestments | - | - | - | -280 | |
| Shareholder | - | -400 | - | 350 | |
| contribution/distribution | |||||
| Other1) | -326 | -384 | -194 | -473 | |
| Increase(-)/decrease(+) in net debt |
-125 | -405 | -181 | -403 | |
| Key ratios | |||||
| Working capital/sales, % | 25 | ||||
| Capital expenditures/sales, % | 4 | ||||
| Balance sheet items, SEK m | 6/30 2023 | 12/31 2022 | |||
| Net debt | 3,735 | 3,330 | |||
| 6/30 2023 | 6/30 2022 | ||||
| Number of employees | 1,830 | 1,755 | |||
1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.
A provider of scientific and analytical instruments for the biotechnology, clinical and food & beverage industries. Read more at www.aicompanies.com
| Income statement items, | 2023 | 2022 | |||
|---|---|---|---|---|---|
| USD m | Q2 | H1 | Q2 | H1 | Last 12 months |
| Sales | 37 | 71 | 33 | 65 | 141 |
| EBITDA | 16 | 28 | 8 | 21 | 52 |
| EBITA | 15 | 27 | 7 | 20 | 49 |
| Sales growth, % | 12 | 10 | 41 | 42 | |
| Organic growth, constant currency, % |
-1 | -5 | 16 | 17 | |
| EBITDA, % | 42.7 | 39.5 | 22.7 | 33.2 | 36.8 |
| EBITA, % | 40.7 | 37.5 | 21.3 | 31.7 | 35.0 |
| Cash flow items, USD m | Q2 | H1 | Q2 | H1 | |
| EBITDA | 16 | 28 | 8 | 21 | |
| Lease payments | 0 | 0 | 0 | 0 | |
| Change in working capital | 1 | -4 | 1 | -7 | |
| Capital expenditures | -1 | -1 | -1 | -1 | |
| Operating cash flow | 16 | 23 | 8 | 13 | |
| Acquisitions/divestments | -1 | -32 | -71 | -71 | |
| Shareholder | - | - | 50 | 50 | |
| contribution/distribution | |||||
| Other1) | -7 | -14 | -2 | -5 | |
| Increase(-)/decrease(+) in net debt |
8 | -23 | -16 | -13 | |
| Key ratios | |||||
| Working capital/sales, % | 9 | ||||
| Capital expenditures/sales, % | 1 | ||||
| Balance sheet items, USD m | 6/30 2023 | 12/31 2022 | |||
| Net debt | 229 | 206 | |||
| 6/30 2023 | 6/30 2022 | ||||
| Number of employees | 325 | 350 | |||
| 1) Includes effects of exchange rate changes, interest, tax and change in lease |
A provider of gripping and moving solutions for end-users and machine manufacturers to improve energy efficiency, productivity and work environment. Read more at www.piab.com
| Income statement items, | 2023 | 2022 | Last 12 | ||
|---|---|---|---|---|---|
| SEK m | Q2 | H1 | Q2 | H1 | months |
| Sales | 789 1,509 | 619 1,169 | 2,790 | ||
| EBITDA | 222 | 428 | 173 | 334 | 712 |
| EBITA | 193 | 374 | 152 | 294 | 610 |
| Sales growth, % | 27 | 29 | 47 | 41 | |
| Organic growth, | |||||
| constant currency, % | 4 | 8 | 17 | 17 | |
| EBITDA, % | 28.2 | 28.3 | 27.9 | 28.6 | 25.5 |
| EBITA, % | 24.5 | 24.8 | 24.5 | 25.2 | 21.9 |
| Cash flow items, SEK m | Q2 | H1 | Q2 | H1 | |
| EBITDA | 222 | 428 | 173 | 334 | |
| Lease payments | -13 | -24 | -10 | -19 | |
| Change in working capital | 14 | -45 | -46 | -130 | |
| Capital expenditures | -24 | -44 | -15 | -26 | |
| Operating cash flow | 199 | 314 | 102 | 159 | |
| Acquisitions/divestments | -12 | -785 | -499 | -695 | |
| Shareholder contribution/distribution |
- | 222 | 210 | 210 | |
| Other1) | -332 | -418 | -250 | -330 | |
| Increase(-)/decrease(+) in net | |||||
| debt | -145 | -667 | -437 | -656 | |
| Key ratios | |||||
| Working capital/sales, % | 18 | ||||
| Capital expenditures/sales, % | 3 | ||||
| Balance sheet items, SEK m | 6/30 2023 | 12/31 2022 | |||
| Net debt | 3,097 | 2,431 | |||
| 6/30 2023 | 6/30 2022 | ||||
| Number of employees | 1,185 | 995 | |||
1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.
A provider of mobility transportation solutions, including wheelchair accessible vehicles, lifts and seating, storage and securement products. Read more at www.braunability.com
| Income statement items, | 2023 | 2022 | Last 12 | |||
|---|---|---|---|---|---|---|
| USD m | Q2 | H1 | Q2 | H1 | months | |
| Sales | 288 | 538 | 211 | 435 | 1,032 | |
| EBITDA | 37 | 70 | 17 | 39 | 117 | |
| EBITA | 32 | 60 | 13 | 30 | 97 | |
| Sales growth, % | 36 | 24 | 24 | 37 | ||
| Organic growth, constant currency, % |
36 | 23 | 19 | 30 | ||
| EBITDA, % | 12.9 | 13.0 | 8.1 | 9.0 | 11.4 | |
| EBITA, % | 11.1 | 11.1 | 5.9 | 6.8 | 9.4 | |
| Cash flow items, USD m | Q2 | H1 | Q2 | H1 | ||
| EBITDA | 37 | 70 | 17 | 39 | ||
| Lease payments | -2 | -4 | -2 | -4 | ||
| Change in working capital | -6 | -32 | -10 | -18 | ||
| Capital expenditures | -5 | -9 | -3 | -5 | ||
| Operating cash flow | 24 | 24 | 3 | 12 | ||
| Acquisitions/divestments | - | - | - | -8 | ||
| Shareholder | - | - | - | - | ||
| contribution/distribution | ||||||
| Other1) | -11 | -18 | -4 | -7 | ||
| Increase(-)/decrease(+) in net debt |
12 | 6 | 0 | -2 | ||
| Key ratios | ||||||
| Working capital/sales, % | 7 | |||||
| Capital expenditures/sales, % | 2 | |||||
| Balance sheet items, USD m | 6/30 2023 | 12/31 2022 | ||||
| Net debt | 277 | 284 | ||||
| 6/30 2023 | 6/30 2022 | |||||
| Number of employees | 2,035 | 1,890 | ||||
Develops and manages properties within community service and commercial. Read more at www.vectura.se
| Income statement items, | 2023 | 2022 | Last 12 | ||
|---|---|---|---|---|---|
| SEK m | Q2 | H1 | Q2 | H1 | months |
| Sales | 82 | 166 | 75 | 150 | 319 |
| EBITDA | 41 | 96 | 47 | 91 | 183 |
| EBITDA, % | 49.5 | 57.7 | 62.0 | 60.8 | 57.4 |
| EBITA adj.1) | 4 | 27 | 15 | 28 | 50 |
| EBITA adj % | 4.7 | 16.4 | 20.1 | 18.7 | 15.6 |
| Balance sheet items, SEK m | 6/30 2023 | 12/31 2022 | |||
| Net debt | 5,901 | 5,223 | |||
| 6/30 2023 | 12/31 2022 | ||||
| Real estate market value | 10,276 | 9,650 | |||
| 6/30 2023 | 6/30 2022 | ||||
| Number of employees | 50 | 41 | |||
1) EBITA adjusted for depreciation of surplus values related to properties.
A provider of advanced reagents for basic and clinical biomedical research. Read more at www.atlasantibodies.com
| Income statement items, | 2023 | 2022 | Last 12 | ||
|---|---|---|---|---|---|
| SEK m | Q2 | H1 | Q2 | H1 | months |
| Sales | 108 | 219 | 104 | 200 | 417 |
| EBITDA | 43 | 97 | 48 | 93 | 191 |
| EBITA | 36 | 82 | 42 | 82 | 164 |
| Sales growth, % | 4 | 9 | 29 | 27 | |
| Organic growth, constant currency, % |
-6 | 1 | 21 | 21 | |
| EBITDA, % | 40.0 | 44.3 | 45.7 | 46.5 | 45.8 |
| EBITA, % | 32.9 | 37.4 | 40.4 | 41.2 | 39.5 |
| Cash flow items, SEK m | Q2 | H1 | Q2 | H1 | |
| EBITDA | 43 | 97 | 48 | 93 | |
| Lease payments | -4 | -7 | -2 | -4 | |
| Change in working capital | 4 | -13 | -22 | -48 | |
| Capital expenditures | -8 | -13 | -6 | -9 | |
| Operating cash flow | 36 | 64 | 18 | 32 | |
| Acquisitions/divestments | - | - | - | - | |
| Shareholder contribution/distribution |
- | - | - | - | |
| Other1) | -1 | -60 | -6 | -17 | |
| Increase(-)/decrease(+) in net | |||||
| debt | 34 | 4 | 12 | 15 | |
| Key ratios | |||||
| Working capital/sales, % | 50 | ||||
| Capital expenditures/sales, % | 5 | ||||
| Balance sheet items, SEK m | 6/30 2023 | 12/31 2022 | |||
| Net debt | 338 | 342 | |||
| 6/30 2023 | 6/30 2022 | ||||
| Number of employees | 120 | 120 | |||
Provides mobile voice and broadband services in Sweden and Denmark. Read more at www.tre.se.
| 2023 | 2022 | Last 12 | |||
|---|---|---|---|---|---|
| Income statement items | Q2 | H1 | Q2 | H1 | months |
| Sales, SEK m | 3,004 6,025 2,798 5,526 | 12,333 | |||
| Sweden, SEK m | 1,908 3,819 1,817 3,566 | 7,921 | |||
| Denmark, DKK m | 708 1,452 | 700 1,394 | 2,963 | ||
| Service revenue, SEK m1) | 2,035 3,996 1,831 3,616 | 7,885 | |||
| Sweden, SEK m | 1,274 2,518 1,169 2,306 | 4,964 | |||
| Denmark, DKK m | 492 | 972 | 472 | 931 | 1,961 |
| EBITDA, SEK m | 989 1,858 | 917 1,807 | 3,779 | ||
| Sweden, SEK m | 716 1,381 | 675 1,331 | 2,782 | ||
| Denmark, DKK m | 177 | 312 | 172 | 339 | 668 |
| EBITDA, % | 32.9 | 30.8 | 32.8 | 32.7 | 30.6 |
| Sweden | 37.5 | 36.2 | 37.2 | 37.3 | 35.1 |
| Denmark | 24.9 | 21.5 | 24.6 | 24.3 | 22.6 |
| Key ratios | |||||
| Capital expenditures/sales, % | 18 | ||||
| Balance sheet items, SEK m | 6/30 2023 | 12/31 2022 | |||
| Net debt | 7,491 | 7,294 | |||
| 6/30 2023 | 6/30 2022 | ||||
| Number of employees | 1,790 | 1,715 | |||
| Other key figures | 6/30 2023 | 6/30 2022 | |||
| Subscriptions | 4,098,000 | 3,901,000 | |||
| Sweden | 2,525,000 | 2,377,000 | |||
| Denmark | 1,573,000 | 1,524,000 | |||
1) Mobile service revenue excluding interconnect revenue.
EQT is a purpose-driven global investment organization focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of almost three decades of delivering consistent and attractive returns across multiple geographies, sectors and strategies. Investor was one of the founders of EQT in 1994 and has committed capital to the vast majority of its funds. Read more at www.eqtgroup.com
• The reported value change of Investments in EQT was 3 percent. Net cash flow to Investor amounted to SEK 536m.
Contribution to net asset value (adjusted and reported) amounted to SEK -272m during the first half of 2023 (-43,126), of which SEK 2,273m during the second quarter (-25,618).
The reported value change of Investor's investments in EQT was 0 percent during the first half of 2023, of which -3 percent in constant currency.
During the second quarter, the value change amounted to 3 percent, of which 1 percent in constant currency.
Net cash flow to Investor amounted to SEK -214m during the first half of 2023, of which SEK 536m during the second quarter.
Total shareholder return for the first half of 2023 amounted to -5 percent, of which -1 percent during the second quarter.
Dividends received amounted to SEK 261m during the first half of 2023, of which SEK 261m during the second quarter.
Investor reports the value change on its EQT fund investments with a one-quarter lag. Consequently, the information related to Investor's investments in EQT funds in this report is presented as of March 31, 2023.
During the first half of 2023, the reported value change of Investor's investments in EQT funds amounted to 6 percent, of which 0 percent in constant currency.
During the second quarter, the reported value change amounted to 8 percent, of which 4 percent in constant currency.
Investor's total outstanding commitments to EQT funds amounted to SEK 24.4bn as of June 30, 2023 (25.6).
| SEK m | Q2 2023 | H1 2023 | H1 2022 |
|---|---|---|---|
| Net asset value, beginning of period |
68,254 | 70,050 | 116,640 |
| Contribution to net asset value Drawdowns (investments, management fees and management |
2,273 | -272 | -43,126 |
| cost) Proceeds to Investor (divestitures, |
439 | 2,310 | 2,740 |
| fee surplus, carry and dividend) | -975 | -2,096 | -6,607 |
| Net asset value, end of period | 69,992 | 69,992 | 69,647 |
Investor
| Fund size |
Outstanding commitment |
Reported value |
||
|---|---|---|---|---|
| EUR m Share (%) | SEK m | SEK m | ||
| Fully invested funds2) | 42,451 | 3,275 | 17,813 | |
| EQT IX | 15,600 | 3 | 635 | 6,509 |
| EQT Infrastructure V | 15,700 | 3 | 1,603 | 4,428 |
| Credit Opportunities III3) | 1,272 | 10 | 588 | 551 |
| EQT Growth | 2,200 | 3 | 517 | 208 |
| EQT Ventures II | 619 | 3 | 12 | 267 |
| EQT Ventures III | 1,000 | 3 | 269 | 75 |
| EQT Mid Market Asia III | 630 | 27 | 228 | 1,799 |
| EQT Mid Market Europe | 1,616 | 9 | 246 | 1,846 |
| EQT Real Estate II | 1,000 | 3 | 181 | 230 |
| EQT new funds | - | - | 16,870 | 65 |
| Total fund investments | 82,088 | 24,425 | 33,793 | |
| EQT AB | 14.7/14.74) | 36,200 | ||
| Total investments in EQT | 69,992 |
1) Investor's investments in EQT funds are reported with a one-quarter lag.
2) EQT VI, EQT VII, EQT VIII, EQT Expansion Capital II, EQT Infrastructure I, II, III and IV, EQT Credit Fund II, EQT Mid Market, EQT Mid Market US, EQT Real Estate I, EQT Ventures.
3) Divested by EQT AB to Bridgepoint, October 2020.
4) Capital and votes respectively.
| SEK m | Q2 2023 |
Q1 2023 |
FY 2022 |
Q4 2022 |
Q3 2022 |
Q2 2022 |
Q1 2022 |
FY 2021 |
Q4 2021 |
Q3 2021 |
Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported value | 69,992 | 68,254 | 70,050 | 70,050 | 70,260 | 69,647 | 99,078 | 116,640 | 116,640 | 90,889 | 78,467 |
| Reported value change, % |
3 | -4 | -35 | 2 | 2 | -26 | -15 | 111 | 30 | 16 | 9 |
| Value change, constant currency, % |
1 | -4 | -37 | 1 | 1 | -27 | -15 | 110 | 30 | 16 | 9 |
| Drawdowns from Investor |
439 | 1,871 | 4,000 | 832 | 428 | 847 | 1,893 | 8,068 | 3,120 | 2,258 | 1,169 |
| Proceeds to Investor | 975 | 1,121 | 10,220 | 2,257 | 1,355 | 4,660 | 1,947 | 12,902 | 4,965 | 2,550 | 4,986 |
| Net cash flow to Investor |
536 | -749 | 6,220 | 1,426 | 927 | 3,813 | 54 | 4,834 | 1,845 | 292 | 3,817 |
Net debt totaled SEK 13,218m on June 30, 2023 (10,263). Debt financing of the Patricia Industries' subsidiaries is arranged without guarantees from Investor and hence not included in Investor's net debt. Investor guarantees SEK 2.4bn of the associated company Three Scandinavia's refinanced external debt, but this guaranteed loan is not included in Investor's net debt. The same applies for pending dividends from investments and approved but not yet paid dividend to shareholders.
| SEK m | Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's net debt |
|---|---|---|---|
| Other financial | |||
| investments | 10,232 | -123 | 10,109 |
| Cash, bank and short term investments Receivables included |
26,174 | -8,793 | 17,382 |
| in net debt | 1,149 | -209 | 941 |
| Interest bearing debt | -96,091 | 54,544 | -41,547 |
| Provision for pensions | -807 | 705 | -102 |
| Total | -59,342 | 46,124 | -13,218 |
Investor's gross cash amounted to SEK 27,491m as of June 30, 2023 (28,533). The short-term investments are invested conservatively, taking into account the riskadjusted return profile. Investor's gross debt, excluding pension liabilities, amounted to SEK 40,606m as of June 30, 2023 (38,695).
The average maturity of Investor AB's debt portfolio was 11.3 years on June 30, 2023 (11.8), excluding the debt of the Patricia Industries subsidiaries.
Investor is rated AA- (Stable Outlook) by S&P Global and Aa3 (Stable Outlook) by Moody's.
| SEK m | Group - Net financial items |
Deductions related to Patricia Industries |
Investor's net financial items |
|---|---|---|---|
| Interest income | 79 | -37 | 41 |
| Interest expenses Results from revaluation of loans, swaps and short |
-1,637 | 1,251 | -386 |
| term investments | -360 | 585 | 225 |
| Foreign exchange result | -1,916 | 85 | -1,831 |
| Other | -180 | 182 | 2 |
| Total | -4,015 | 2,066 | -1,950 |
Investor's share capital amounted to SEK 4,795m on June 30, 2023 (4,795).
| Share structure | ||||
|---|---|---|---|---|
| Class of share |
Number of shares |
Number of votes |
% of capital |
% of votes |
| A 1 vote | 1,246,763,376 | 1,246,763,376 | 40.6 | 87.2 |
| B 1/10 vote | 1,821,936,744 | 182,193,674 | 59.4 | 12.8 |
| Total | 3,068,700,120 | 1,428,957,050 | 100.0 | 100.0 |
Investor's share capital consists of 3,068,700,120 shares with a quota of SEK 1.5625 per share.
On June 30, 2023, Investor owned a total of 6,174,413 of its own shares (5,654,344).
The Parent Company's result after financial items was SEK 80,653m (-78,215). The result is mainly related to Listed Companies which contributed to the result with dividends amounting to SEK 8,762m (7,866) and value changes of SEK 74,369m (-84,631).
During 2023, the Parent Company invested SEK 562m in financial assets (3,349), of which SEK 562m in Group companies (495) as new loans and capitalization of interest and purchases in Listed Companies of SEK 0m (501). The Parent Company divested SEK 990m in Listed Companies during the year (1,662). During the year, the Parent Company received repayments of shareholder contribution of 8,950m (8 650) and repayments of loans of 421m (0) from subsidiaries. By the end of the period, Shareholder's equity totaled SEK 498,072m (431,034).
On May 3, 2023, Investor AB's Annual General Meeting (AGM) approved the Board of Directors' proposal of a dividend to the shareholders of SEK 4.40 per share for fiscal year 2022 (4.00). SEK 3.30 was paid out on May 10, 2023, and SEK 1.10 per share will be paid out on November 9, 2023.
Investor continues to offer chairpersons in companies within Listed Companies to invest in call options in their respective companies with a duration of five to seven
years, as the chairperson has a particularly important role in driving successful board work.
During the second quarter 2023, new 5-year options, with a strike price of 110 percent of the share price, were sold to the chairperson in Atlas Copco for a total consideration of SEK 5m.
During the first quarter 2023, five-year call options with a strike price of 110 percent have been sold to the chairperson of Epiroc for a total SEK 2m.
On April 20, 2023, Piab finalized the acquisition of IB Verfahrens- und Anlagentechnik GmbH & Co. KG. IB develops and builds customer-specific, turnkey systems for filling, emptying, metering, and conveying bulk materials. The consideration amounted to SEK 116m and was funded in cash. The acquisition of IB product portfolio completes the Piab additive manufacturing offering and enables Piab Group to offer full powder handling solutions, particularly in the Food, Pharma and Chemical industries. In the preliminary purchase price allocation, goodwill amounted to SEK 115m. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 9m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until June 30, 2023, IB contributed net sales of SEK 12m and profit/loss of SEK 0m to the Group's result. If the acquisition had occurred on January 1, 2023,
management estimates that consolidated net sales for the Group would have increased by SEK 20m and consolidated profit/loss for the period would have increased by SEK 2m.
On March 28, 2023, Piab finalized the acquisition of COVAL, a global player in vacuum automation components and systems. The consideration amounted to SEK 715m and was funded with SEK 222m in equity from Patricia Industries, in addition to cash from Piab and external debt. The acquisition strengthens Piab's product portfolio and geographic footprint. In the preliminary purchase price allocation, goodwill amounted to SEK 400m. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 23m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until June 30, 2023, COVAL contributed net sales of SEK 84m and profit/loss of SEK 13m to the Group's result. If the acquisition of COVAL had occurred on January 1, 2023, management estimates that consolidated net sales for the Group would have increased by SEK 67m and consolidated profit/loss for the period would have increased by SEK 7m. In connection with the closing of the acquisition of COVAL a loan amounting to SEK 96m was repaid.
| SEK m | IB | COVAL | Total |
|---|---|---|---|
| Intangible assets | 2 | 234 | 235 |
| Property, plant and equipment | 0 | 75 | 75 |
| Inventories | 14 | 40 | 53 |
| Trade receivables | 8 | 46 | 54 |
| Other current receivables | 3 | 7 | 10 |
| Cash and cash equivalents | 9 | 38 | 46 |
| Long-term interest bearing liabilities | -15 | -96 | -111 |
| Other provisions | -2 | -4 | -6 |
| Other liabilities | -17 | -24 | -41 |
| Net identifiable assets and liabilities | 1 | 315 | 316 |
| Consolidated goodwill | 115 | 400 | 515 |
| Consideration | 116 | 715 | 832 |
| Less: acquired cash and cash equivalents | -9 | -38 | -46 |
| Paid additional purchased price related to acquisitions made in previous periods | 340 | ||
| Acquisitions of subsidiaries, net effect on cash flow | 108 | 677 | 1,125 |
Total pledged assets amount to SEK 31.0bn (29.8), of which SEK 28.3bn (27.5) refers to pledged assets in the subsidiaries BraunAbility, Laborie, Advanced Instruments and Sarnova, related to outstanding loans corresponding to SEK 2.6bn, SEK 4.5bn, SEK 2.1bn and SEK 5.6bn.
Total contingent liabilities amount to SEK 2.5bn and refers to warranties within the wholly-owned subsidiaries (1.6).
In January 2023, Vectura and Saab entered into a share purchase agreement and a lease agreement for new premises. Vectura shall produce and finance a new construction project with premises adapted for Saab. Access to the premises is expected by the end of 2025. The lease agreement has an initial term of 20 years. The total net present value of the transactions amounts to approximately SEK 610m.
The main risks that the Group and the Parent Company are exposed to are primarily related to the value changes of the listed assets due to market price fluctuations. The current uncertain market environment creates unpredictable near-term fluctuations in the financial markets. The global market development also affects the businesses of Investor's unlisted holdings'. The global economy continues to be affected by geopolitical tensions, Russia's invasion of Ukraine, supply chain constraints as well as inflation and interest rates. Investor's portfolio companies operate in several different industries, and they all face different situations. Based on Investor's governance model, each individual board and management team decides on appropriate actions related to the company's risks.
All companies have taken measures related to Russia's invasion of Ukraine, such as following sanctions, protecting and supporting employees, and several have wound down their Russian activities. The direct exposure to Russia and Ukraine is very small for Investor and its subsidiaries, and the direct financial impact from the war is negligible. However, the indirect impact due to fluctuations in the financial markets, higher prices on raw materials, inflation and central bank policies, can be substantial, but it is not possible to quantify these effects for the coming year. In 2022, Investor's net sales to Russia and Ukraine (related to the subsidiaries within Patricia Industries) amounted to less than SEK 100 m, corresponding to 0.19 percent of net sales for the Group. The Group has no production plants or other assets in the countries concerned. During the first and second quarter of 2023, no impairment has been made related to Russia's invasion of Ukraine.
Investor's risk management, risks and uncertainties are described more in detail in the Annual Report, (Administration report and Note 3).
For the Group, this Interim Report is prepared in accordance with IAS 34 Interim Financial Reporting and applicable regulations in the Swedish Annual Accounts Act, and for the Parent Company in accordance with Sweden's Annual Accounts Act, chapter 9 Interim report. The accounting policies that have been applied for the Group and Parent Company, are in agreement with the accounting policies used in preparation of the company's most recent annual report.
Investor applies the ESMA Guidelines on Alternative Performance Measures (APMs). An APM is a financial measure of historical or future financial performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework. For Investor's consolidated accounts, this framework typically means IFRS.
Definitions of all APMs used are found in the Annual Report 2022 and on www.investorab.com/investorsmedia/investor-in-figures/definitions.
Reconciliations to the financial statements for the APMs that are not directly identifiable from the financial statements and considered significant to specify, are disclosed on pages 31-32. Reconciliations of APMs for individual subsidiaries or business areas are not disclosed, since the purpose of these are to give deeper financial information without being directly linked to the financial
information for the Group, that is presented according to the applicable financial reporting framework.
Due to rounding, numbers presented throughout this Interim Report may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
| Oct. 19, 2023 | Interim Management Statement January-September 2023 |
|---|---|
| Jan. 19, 2024 | Year-End Report 2023 |
| Apr. 18, 2024 | Interim Management Statement January-March 2024 |
| Jul. 17, 2024 | Interim Report |
January-June 2024
Helena Saxon Chief Financial Officer +46 8 614 2000 [email protected]
Viveka Hirdman-Ryrberg Head of Corporate Communication and Sustainability +46 70 550 3500 [email protected]
Magnus Dalhammar Head of Investor Relations +46 73 524 2130 [email protected]
Investor AB (publ) (CIN 556013-8298) SE-103 32 Stockholm, Sweden Visiting address: Arsenalsgatan 8C Phone: +46 8 614 2000 www.investorab.com
Ticker codes
INVEB SS in Bloomberg INVEb.ST in Reuters INVE B in NASDAQ OMX
Information about Investor is also available on LinkedIn.
This information is information that Investor AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, at 12:00 CET on July 17, 2023.
This Interim Report and additional information is available on www.investorab.com
The Board of Directors declares that the six-month Interim Report provides a true and fair overview of the Parent Company's and Group's operations, their financial position and performance, and describes material risks and uncertainties facing the Parent Company and other companies in the Group.
Stockholm, July 17, 2023
Jacob Wallenberg Chairman
Tom Johnstone, CBE Grace Reksten Skaugen Marcus Wallenberg
Hans Stråberg Isabelle Kocher Sven Nyman
Gunnar Brock Sara Öhrvall Magdalena Gerger Director Director Director
Director Director Vice Chairman
Director Director Director
Johan Forssell President and Chief Executive Officer Director
We have reviewed the Interim report of Investor AB (publ), corporate identity number 556013-8298, for the period January 1-June 30, 2023. The Board of Directors and the President are responsible for the preparation and presentation of this interim report in accordance with IAS 34 and the Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review.
We conducted our review in accordance with the International Standard on Review Engagements ISRE 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review has a different focus and is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (ISA) and other generally accepted auditing practices. The procedures performed in a review do not enable us to obtain a level of assurance that would
make us aware of all significant matters that might be identified in an audit.
Therefore, the conclusion expressed based on a review does not give the same level of assurance as a conclusion expressed based on an audit.
Based on our review, nothing has come to our attention that causes us to believe that the Interim report is not, in all material respects, prepared for the Group in accordance with IAS 34 and the Annual Accounts Act, and for the Parent Company in accordance with the Annual Accounts Act.
Stockholm, July 17, 2023
Deloitte AB
For signature, please see Swedish version
Jonas Ståhlberg
Authorized Public Accountant
| SEK m | H1 2023 | H1 2022 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Dividends | 9,432 | 8,453 | 5,218 | 1,782 |
| Changes in value | 69,670 | -141,384 | 41,309 | -65,808 |
| Net sales | 28,841 | 23,929 | 14,831 | 12,280 |
| Cost of goods and services sold | -15,323 | -13,113 | -7,859 | -6,711 |
| Sales and marketing cost | -4,274 | -3,615 | -2,180 | -1,830 |
| Administrative, research and development and other operating cost |
-5,320 | -4,794 | -2,717 | -2,500 |
| Management cost | -316 | -285 | -162 | -152 |
| Share of results of associates | 72 | 8 | 45 | -18 |
| Operating profit/loss | 82,781 | -130,800 | 48,486 | -62,957 |
| Net financial items | -4,015 | -3,493 | -2,832 | -2,366 |
| Profit/loss before tax | 78,766 | -134,294 | 45,654 | -65,323 |
| Income taxes | -645 | -352 | -346 | -198 |
| Profit/loss for the period | 78,121 | -134,646 | 45,309 | -65,521 |
| Attributable to: | ||||
| Owners of the Parent Company | 78,191 | -134,582 | 45,343 | -65,490 |
| Non-controlling interest | -70 | -64 | -35 | -31 |
| Profit/loss for the period | 78,121 | -134,646 | 45,309 | -65,521 |
| Basic earnings per share, SEK | 25.53 | -43.93 | 14.80 | -21.38 |
| Diluted earnings per share, SEK | 25.51 | -43.93 | 14.80 | -21.38 |
| SEK m | H1 2023 | H1 2022 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Profit/loss for the period | 78,121 | -134,646 | 45,309 | -65,521 |
| Other comprehensive income for the period, including tax | ||||
| Re-measurements of defined benefit plans | 15 | 65 | 15 | 65 |
| Items that may be recycled to profit/loss for the period | ||||
| Cash flow hedges | 5 | 51 | 7 | 16 |
| Hedging costs | 15 | 77 | 10 | 60 |
| Foreign currency translation adjustment | 4,528 | 6,297 | 4,136 | 5,002 |
| Share of other comprehensive income of associates | 79 | 60 | 83 | 39 |
| Total other comprehensive income for the period | 4,641 | 6,550 | 4,251 | 5,182 |
| Total comprehensive income for the period | 82,762 | -128,096 | 49,560 | -60,338 |
| Attributable to: | ||||
| Owners of the Parent Company | 82,823 | -128,066 | 49,572 | -60,336 |
| Non-controlling interest | -60 | -30 | -12 | -3 |
| Total comprehensive income for the period | 82,762 | -128,096 | 49,560 | -60,338 |
| SEK m | 6/30 2023 | 12/31 2022 | 6/30 2022 |
|---|---|---|---|
| ASSETS | |||
| Goodwill | 66,801 | 63,334 | 61,828 |
| Other intangible assets | 34,293 | 34,355 | 35,315 |
| Property, plant and equipment | 12,940 | 16,239 | 14,898 |
| Shares and participations | 621,530 | 550,556 | 493,460 |
| Other financial investments | 10,232 | 9,705 | 11,585 |
| Long-term receivables included in net debt | 1,149 | 945 | 1,230 |
| Other long-term receivables | 3,272 | 2,873 | 3,022 |
| Total non-current assets | 750,218 | 678,006 | 621,338 |
| Inventories | 10,682 | 9,583 | 8,836 |
| Shares and participations in trading operation | 1,049 | 873 | 205 |
| Short-term receivables included in net debt | - | - | 2 |
| Other current receivables | 10,592 | 9,598 | 10,789 |
| Cash, bank and short-term investments | 26,174 | 26,304 | 27,955 |
| Assets held for sale | 4,434 | - | - |
| Total current assets | 52,932 | 46,358 | 47,786 |
| TOTAL ASSETS | 803,150 | 724,365 | 669,124 |
| EQUITY AND LIABILITIES | |||
| Equity | 674,817 | 605,653 | 542,760 |
| Long-term interest bearing liabilities | 84,204 | 89,436 | 87,728 |
| Provisions for pensions and similar obligations | 807 | 799 | 1,022 |
| Other long-term provisions and liabilities | 15,559 | 14,973 | 15,477 |
| Total non-current liabilities | 100,569 | 105,209 | 104,227 |
| Current interest bearing liabilities | 11,887 | 1,783 | 8,984 |
| Other short-term provisions and liabilities | 15,656 | 11,719 | 13,153 |
| Liabilities directly associated with assets held for sale | 221 | - | - |
| Total current liabilities | 27,764 | 13,502 | 22,137 |
| TOTAL EQUITY AND LIABILITIES | 803,150 | 724,365 | 669,124 |
| SEK m | H1 2023 | 2022 | H1 2022 |
|---|---|---|---|
| Opening balance 1/1 | 605,653 | 683,505 | 683,505 |
| Profit for the period | 78,121 | -74,762 | -134,646 |
| Other comprehensive income for the period | 4,641 | 9,550 | 6,550 |
| Total comprehensive income for the period | 82,762 | -65,212 | -128,096 |
| Dividend to shareholders | -13,477 | -12,254 | -12,254 |
| Changes in non-controlling interest | 21 | -282 | -260 |
| Effect of long-term share-based remuneration | 56 | 42 | 11 |
| Purchase of own shares | -199 | -147 | -147 |
| Closing balance | 674,817 | 605,653 | 542,760 |
| Attributable to: | |||
| Owners of the Parent Company | 674,068 | 604,865 | 541,955 |
| Non-controlling interest | 749 | 788 | 805 |
| Total equity | 674,817 | 605,653 | 542,760 |
| Consolidated Cash Flow, in summary | ||
|---|---|---|
| SEK m | H1 2023 | H1 2022 |
| Operating activities | ||
| Dividends received | 9,432 | 8,533 |
| Cash receipts | 27,472 | 21,584 |
| Cash payments | -22,999 | -19,158 |
| Cash flows from operating activities before net interest and income tax | 13,905 | 10,959 |
| Interest received/paid | -1,313 | -1,284 |
| Income tax paid | -691 | -681 |
| Cash flows from operating activities | 11,900 | 8,994 |
| Investing activities | ||
| Acquisitions1) | -2,742 | -2,762 |
| Divestments2) | 3,311 | 8,109 |
| Increase in long-term receivables | -106 | -19 |
| Decrease in long-term receivables | -1 | 19 |
| Acquisitions of subsidiaries, net effect on cash flow | -1,158 | -2,137 |
| Divestments of subsidiaries, net effect on cash flow | - | 67 |
| Increase in other financial investments3) | -7,670 | -439 |
| Decrease in other financial investments4) | 7,340 | 3,142 |
| Net change, short-term investments5) | 3,796 | -4,715 |
| Acquisitions of property, plant and equipment | -1,571 | -2,627 |
| Proceeds from sale of property, plant and equipment | 15 | 328 |
| Net cash used in investing activities | 1,214 | -1,035 |
| Financing activities | ||
| New share issue | - | 21 |
| Borrowings | 2,616 | 11,726 |
| Repayment of borrowings | -2,256 | -6,097 |
| Repurchases of own shares | -204 | -147 |
| Dividend paid | -10,130 | -9,191 |
| Net cash used in financing activities | -9,974 | -3,687 |
| Cash flows for the period | 3,140 | 4,272 |
| Cash and cash equivalents at the beginning of the year | 13,164 | 18,330 |
| Exchange difference in cash | 440 | 489 |
| Cash and cash equivalents at the end of the period | 16,745 | 23,091 |
1) Acquisitions include investments in listed and unlisted companies not defined as subsidiaries.
2) Divestments include sale of listed and unlisted companies not defined as subsidiaries.
3) Increase in other financial investments include acquisition of bond with maturity later than 1 year.
4) Decrease in other financial investments include disposals of reclassification of bonds with maturity later than 1 year.
5) Net changes, short-term investments includes acquisitions and disposals of bonds and certificates with maturity within 1 year.
| Listed | Patricia | Investments in | Investor | ||
|---|---|---|---|---|---|
| SEK m | Companies | Industries | EQT | Groupwide | Total |
| Dividends | 4,953 | - | 261 | 3 | 5,218 |
| Changes in value | 40,736 | -18 | 607 | -16 | 41,309 |
| Net sales | - | 14,831 | - | - | 14,831 |
| Cost of goods and services sold | - | -7,859 | - | - | -7,859 |
| Sales and marketing cost | - | -2,180 | - | - | -2,180 |
| Administrative, research and development and other operating cost | - | -2,713 | -1 | -3 | -2,717 |
| Management cost | -40 | -80 | -3 | -39 | -162 |
| Share of results of associates | - | 45 | - | - | 45 |
| Operating profit/loss | 45,649 | 2,027 | 864 | -54 | 48,486 |
| Net financial items | - | -1,382 | - | -1,449 | -2,832 |
| Income tax | - | -232 | - | -113 | -346 |
| Profit/loss for the period | 45,649 | 412 | 864 | -1,617 | 45,309 |
| Non-controlling interest | - | 35 | - | 0 | 35 |
| Net profit/loss for the period attributable to the Parent Company | 45,649 | 447 | 864 | -1,617 | 45,343 |
| Dividend to shareholders | - | - | - | -13,477 | -13,477 |
| Other effects on equity | - | 2,711 | 1,409 | -60 | 4,060 |
| Contribution to net asset value | 45,649 | 3,158 | 2,273 | -15,155 | 35,926 |
| Net asset value by business area 6/30 2023 | |||||
| Carrying amount | 546,431 | 74,482 | 69,992 | -3,620 | 687,285 |
| Investors net debt/-cash | - | 11,530 | - | -24,748 | -13,218 |
| Total net asset value including net debt/-cash | 546,431 | 86,013 | 69,992 | -28,368 | 674,068 |
| Listed | Patricia | Investments in | Investor | ||
|---|---|---|---|---|---|
| SEK m | Companies | Industries | EQT | Groupwide | Total |
| Dividends | 1,537 | - | 244 | 1 | 1,782 |
| Changes in value | -38,322 | -605 | -26,880 | 0 | -65,808 |
| Net sales | - | 12,280 | - | - | 12,280 |
| Cost of goods and services sold | - | -6,711 | - | 0 | -6,711 |
| Sales and marketing cost | - | -1,830 | - | - | -1,830 |
| Administrative, research and development and other operating cost | - | -2,493 | -1 | -6 | -2,500 |
| Management cost | -37 | -78 | -3 | -34 | -152 |
| Share of results of associates | - | -18 | - | - | -18 |
| Operating profit/loss | -36,822 | 545 | -26,640 | -39 | -62,957 |
| Net financial items | - | -1,062 | - | -1,304 | -2,366 |
| Income tax | - | -142 | - | -56 | -198 |
| Profit/loss for the period | -36,822 | -659 | -26,640 | -1,400 | -65,521 |
| Non-controlling interest | - | 31 | - | 0 | 31 |
| Net profit/loss for the period attributable to the Parent Company | -36,822 | -628 | -26,640 | -1,400 | -65,490 |
| Dividend to shareholders | - | - | - | -12,254 | -12,254 |
| Other effects on equity | - | 3,797 | 1,022 | 9 | 4,828 |
| Contribution to net asset value | -36,822 | 3,169 | -25,618 | -13,645 | -72,916 |
| Net asset value by business area 6/30 2022 | |||||
| Carrying amount | 417,215 | 72,822 | 69,647 | -3,265 | 556,419 |
| Investors net debt/-cash | - | 7,340 | - | -21,804 | -14,464 |
| Total net asset value including net debt/-cash | 417,215 | 80,162 | 69,647 | -25,069 | 541,955 |
| Listed | Patricia | Investments in | Investor | ||
|---|---|---|---|---|---|
| SEK m | Companies | Industries | EQT | Groupwide | Total |
| Dividends | 9,165 | - | 261 | 6 | 9,432 |
| Changes in value | 72,123 | -108 | -2,338 | -6 | 69,670 |
| Net sales | - | 28,841 | - | - | 28,841 |
| Cost of goods and services sold | - | -15,323 | - | - | -15,323 |
| Sales and marketing cost | - | -4,274 | - | - | -4,274 |
| Administrative, research and development and other operating cost | - | -5,305 | -3 | -13 | -5,320 |
| Management cost | -79 | -157 | -5 | -74 | -316 |
| Share of results of associates | - | 72 | - | - | 72 |
| Operating profit/loss | 81,209 | 3,745 | -2,085 | -87 | 82,781 |
| Net financial items | - | -2,066 | - | -1,950 | -4,015 |
| Income tax | - | -518 | - | -127 | -645 |
| Profit/loss for the period | 81,209 | 1,161 | -2,085 | -2,164 | 78,121 |
| Non-controlling interest | - | 70 | - | 0 | 70 |
| Net profit/loss for the period attributable to the Parent Company | 81,209 | 1,231 | -2,085 | -2,164 | 78,191 |
| Dividend to shareholders | - | - | - | -13,477 | -13,477 |
| Other effects on equity | - | 2,699 | 1,813 | -23 | 4,489 |
| Contribution to net asset value | 81,209 | 3,930 | -272 | -15,664 | 69,203 |
| Net asset value by business area 6/30 2023 | |||||
| Carrying amount | 546,431 | 74,482 | 69,992 | -3,620 | 687,285 |
| Investors net debt/-cash | - | 11,530 | - | -24,748 | -13,218 |
| Total net asset value including net debt/-cash | 546,431 | 86,013 | 69,992 | -28,368 | 674,068 |
| Listed | Patricia | Investments in | Investor | ||
|---|---|---|---|---|---|
| SEK m | Companies | Industries | EQT | Groupwide | Total |
| Dividends | 8,207 | - | 244 | 2 | 8,453 |
| Changes in value | -96,214 | -434 | -44,698 | -38 | -141,384 |
| Net sales | - | 23,929 | - | - | 23,929 |
| Cost of goods and services sold | - | -13,113 | - | 0 | -13,113 |
| Sales and marketing cost | - | -3,615 | - | - | -3,615 |
| Administrative, research and development and other operating cost | - | -4,777 | -2 | -15 | -4,794 |
| Management cost | -69 | -149 | -5 | -62 | -285 |
| Share of results of associates | - | 8 | - | - | 8 |
| Operating profit/loss | -88,076 | 1,850 | -44,461 | -113 | -130,800 |
| Net financial items | - | -1,397 | - | -2,096 | -3,493 |
| Income tax | - | -340 | - | -13 | -352 |
| Profit/loss for the period | -88,076 | 113 | -44,461 | -2,222 | -134,646 |
| Non-controlling interest | - | 64 | - | 0 | 64 |
| Net profit/loss for the period attributable to the Parent Company | -88,076 | 177 | -44,461 | -2,222 | -134,582 |
| Dividend to shareholders | - | - | - | -12,254 | -12,254 |
| Other effects on equity | - | 4,807 | 1,335 | 35 | 6,178 |
| Contribution to net asset value | -88,076 | 4,984 | -43,126 | -14,441 | -140,659 |
| Net asset value by business area 6/30 2022 | |||||
| Carrying amount | 417,215 | 72,822 | 69,647 | -3,265 | 556,419 |
| Investors net debt/-cash | - | 7,340 | - | -21,804 | -14,464 |
| Total net asset value including net debt/-cash | 417,215 | 80,162 | 69,647 | -25,069 | 541,955 |
| Parent Company Income Statement, in summary | ||||
|---|---|---|---|---|
| SEK m | H1 2023 | H1 2022 | Q2 2023 | Q2 2022 |
| Dividends | 8,762 | 7,866 | 4,822 | 1,428 |
| Changes in value | 74,367 | -84,645 | 39,709 | -35,786 |
| Net sales | 6 | 8 | 3 | 4 |
| Operating cost | -250 | -221 | -128 | -119 |
| Operating profit/loss | 82,885 | -76,992 | 44,405 | -34,473 |
| Profit/loss from financial items | ||||
| Net financial items | -2,232 | -1,223 | -1,586 | -783 |
| Profit/loss after financial items | 80,653 | -78,215 | 42,820 | -35,257 |
| Income tax | - | - | - | - |
| Profit/loss for the period | 80,653 | -78,215 | 42,820 | -35,257 |
The numbers below are based on the same accounting and valuation policies as used in the preparation of the company's most recent annual report. For information regarding financial instruments in level 2 and level 3, see Note 31, Financial Instruments, in Investor's Annual Report 2022.
| Fair value, SEK m | Range | |||||
|---|---|---|---|---|---|---|
| Group | 6/30 2023 | 12/31 2022 | Valuation technique | Input | 6/30 2023 | 12/31 2022 |
| Shares and participations | 36,097 | 34,184 | Last round of financing | n/a | n/a | n/a |
| Comparable companies | EBITDA multiples | n/a | n/a | |||
| Comparable companies | Sales multiples | 1.3 – 3.4 | 0.9 – 3.3 | |||
| Comparable transactions | Sales multiples | 1.7 – 3.0 | 1.2 – 2.5 | |||
| NAV | n/a | n/a | n/a | |||
| Other financial investments | 26 | 25 | Discounted cash flow | Market interest rate | n/a | n/a |
| Long-term and current receivables | 2,957 | 2,543 | Discounted cash flow | Market interest rate | n/a | n/a |
| Long-term interest bearing liabilities | 16 | 17 | Discounted cash flow | Market interest rate | n/a | n/a |
Other provisions and liabilities 7,358 6,735 Comparable companies EBITDA multiples n/a n/a All valuations in level 3 are based on assumptions and judgments that management considers to be reasonable based on the circumstances prevailing at the time. Changes in assumptions may result in adjustments to reported values and the actual outcome may differ from the estimates and judgments that were made. Shares and participations in level 3 are mainly fund investments within EQT. Unlisted holdings in funds are measured at Investor's share of the value that the fund manager reports for all unlisted fund holdings (Net Asset Value) and is normally updated when a new valuation is received. The value change on Investor's investments in EQT funds are reported with a one-quarter lag. Part of the unlisted portfolio is valued based on comparable companies, and the value is dependent on the level of the multiples. The multiple ranges provided in the note show the minimum and maximum value of the actual multiples applied in these valuations. A 10 percent change of the multiples would have an effect on this part of the unlisted portfolio of approximately SEK 160m (200). For the derivatives, a parallel shift of the interest rate curve by one percentage point would affect the value by approximately SEK 640m (660).
The table below indicates how fair value is measured for the financial instruments recognized at fair value in the Balance Sheet. The financial instruments are presented in three categories, depending on how the fair value is measured: Level 1: According to quoted prices in active markets for identical instruments
Level 2: According to directly or indirectly observable inputs that are not included in level 1
Level 3: According to inputs that are unobservable in the market
| 6/30 2023 | 12/31 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Group | Total carrying |
Total carrying |
||||||||
| SEK m | Level 1 | Level 2 | Level 3 | Other1) | amount | Level 1 | Level 2 | Level 3 | Other1) | amount |
| Financial assets | ||||||||||
| Shares and participations | 579,976 | 2,713 | 36,097 | 2,743 | 621,530 | 511,703 | 2,167 | 34,184 | 2,502 | 550,556 |
| Other financial investments | 10,110 | - | 26 | 96 | 10,232 | 9,591 | - | 25 | 89 | 9,705 |
| Long-term receivables included in net debt |
- | 92 | 1,058 | - | 1,149 | - | - | 945 | - | 945 |
| Other long-term receivables | - | - | 1,900 | 1,373 | 3,272 | - | - | 1,598 | 1,275 | 2,873 |
| Shares and participations in trading operation |
1,049 | - | - | - | 1,049 | 873 | - | - | - | 873 |
| Other current receivables | - | 18 | - | 10,574 | 10,592 | 0 | 41 | - | 9,557 | 9,598 |
| Cash, bank and short-term investments |
17,174 | - | - | 9,001 | 26,174 | 18,767 | - | - | 7,537 | 26,304 |
| Total | 608,309 | 2,823 | 39,081 | 23,787 | 674,000 | 540,935 | 2,208 | 36,752 | 20,960 | 600,855 |
| Financial liabilities | ||||||||||
| Long-term interest bearing liabilities |
- | - | 16 | 84,188 | 84,2042) | - | - | 17 | 89,420 | 89,4362) |
| Other long-term provisions and liabilities |
- | - | 7,316 | 8,243 | 15,559 | - | - | 6,692 | 8,282 | 14,973 |
| Short-term interest bearing liabilities |
- | - | - | 11,887 | 11,8873) | - | 48 | - | 1,735 | 1,7833) |
| Other short-term provisions and liabilities |
159 | 94 | 42 | 15,361 | 15,656 | 179 | 77 | 44 | 11,419 | 11,719 |
| Total | 159 | 94 | 7,374 | 119,679 | 127,306 | 179 | 125 | 6,752 | 110,856 | 117,912 |
1) To enable reconciliation with balance sheet items, financial instruments not valued at fair value as well as other assets and liabilities that are included within balance sheet items
have been included within Other. 2) The Group's loans are valued at amortized cost. Fair value on long-term loans amounts to SEK 76,551m (80,997).
3) The Group's loans are valued at amortized cost. Fair value on short-term loans amounts to SEK 11,792m (1,783).
| Shares and | Other financial |
Long-term receivables included in |
Long-term interest bearing |
Other long term provisions and |
Other current |
|
|---|---|---|---|---|---|---|
| SEK m | participations | investments | net debt | liabilities | liabilities | liabilities |
| Opening balance at the beginning of the year | 34,184 | 25 | 2,543 | 17 | 6,692 | 44 |
| Total gain or losses in profit or loss statement | ||||||
| in line Changes in value | 6 | - | 294 | - | -35 | - |
| in line Net financial items | - | - | 143 | 0 | 588 | -2 |
| Reported in other comprehensive income | ||||||
| in line Cash flow hedges | - | - | -35 | |||
| in line Foreign currency translation adjustment | 1,976 | 1 | 5 | - | 217 | 0 |
| Acquisitions | 2,213 | - | 12 | - | - | - |
| Divestments | -2,237 | - | - | - | -141 | - |
| Issues | - | - | - | - | 4 | - |
| Settlements | - | - | -5 | - | -9 | - |
| Transfer out of Level 3 | -44 | - | - | - | - | - |
| Carrying amount at end of the period | 36,097 | 26 | 2,957 | 16 | 7,316 | 42 |
| Total unrealized gains/losses for the period included in profit/loss for financial instruments held at the end of the period |
||||||
| Changes in value | 3,750 | - | 294 | - | -3 | - |
| Net financial items | - | - | 143 | 0 | -536 | - |
| Total | 3,750 | - | 437 | 0 | -540 | - |
| SEK m | Shares and participations |
Other financial investments |
Long-term receivables included in net debt |
Long-term interest bearing liabilities |
Other long term provisions and liabilities |
Other current liabilities |
|---|---|---|---|---|---|---|
| Opening balance at the beginning of the year | 33,756 | 160 | 3,745 | 46 | 5,935 | 101 |
| Total gain or losses in profit or loss statement | ||||||
| in line Changes in value | 3,789 | -26 | -139 | - | -1 | - |
| in line Net financial items | - | -4 | -1,168 | -29 | 209 | -55 |
| in line Cost of goods and services sold | 0 | - | - | - | -4 | - |
| Reported in other comprehensive income | ||||||
| in line Cash flow hedges | 144 | |||||
| in line Foreign currency translation adjustment | 3,308 | 18 | 44 | - | 562 | 1 |
| Acquisitions | 3,671 | - | - | - | - | - |
| Divestments | -10,341 | -116 | - | - | - | - |
| Issues | - | - | 11 | - | - | - |
| Settlements | - | - | -95 | - | -9 | -3 |
| Transfer out of Level 3 | - | -6 | - | - | - | - |
| Carrying amount at end of the period | 34,184 | 25 | 2,543 | 17 | 6,692 | 44 |
| Total unrealized gains/losses for the period included in profit/loss for financial instruments held at the end of the period |
||||||
| Changes in value | -2,435 | - | - | - | -65 | - |
| Net financial items | - | - | -1,168 | 29 | - | - |
| Total | -2,435 | - | -1,168 | 29 | -65 | - |
As a consequence of a review of Investor's field of operations within Patricia Industries, a new field of operation has been created, Life Science. The new field of operation includes the former fields Health care services and Osmolality testing. Comparative figures have been reclassified to conform to the presentation of the current year's figures.
| Group H1 2023 | Field of operations | ||||
|---|---|---|---|---|---|
| SEK m | Healthcare equipment |
Life science | Real estate | Gripping and moving solutions |
Total |
| Geographical market | |||||
| Sweden | 480 | 77 | 157 | 57 | 771 |
| Scandinavia, excl. Sweden | 755 | 11 | - | 34 | 800 |
| Europe, excl. Scandinavia | 6,377 | 247 | - | 611 | 7,235 |
| U.S. | 16,152 | 607 | - | 427 | 17,186 |
| North America, excl. U.S. | 485 | 35 | - | 86 | 606 |
| South America | 209 | 5 | - | 54 | 268 |
| Africa | 204 | 3 | - | 5 | 212 |
| Australia | 531 | 10 | - | 5 | 546 |
| Asia, excl. China | 569 | 36 | - | 70 | 674 |
| China | 361 | 22 | - | 160 | 544 |
| Total | 26,123 | 1,053 | 157 | 1,509 | 28,841 |
| Category | |||||
| Sales of products | 25,056 | 709 | - | 1,481 | 27,246 |
| Sales of services | 1,031 | 344 | - | 28 | 1,403 |
| Revenues from leasing | 32 | - | 156 | - | 188 |
| Other income | 3 | 0 | 1 | - | 4 |
| Total | 26,123 | 1,053 | 157 | 1,509 | 28,841 |
| Sales channels | |||||
| Through distributors | 14,849 | 381 | - | 832 | 16,062 |
| Directly to customers | 11,275 | 671 | 157 | 677 | 12,780 |
| Total | 26,123 | 1,053 | 157 | 1,509 | 28,841 |
| Timing of revenue recognition | |||||
| Goods and services transferred | |||||
| at a point of time | 25,851 | 964 | - | 1,509 | 28,324 |
| Goods and services transferred | |||||
| over time | 273 | 88 | 157 | - | 518 |
| Total | 26,123 | 1,053 | 157 | 1,509 | 28,841 |
| Healthcare | Gripping and moving |
||||
|---|---|---|---|---|---|
| SEK m | equipment | Life science | Real estate | solutions | Total |
| Geographical market | |||||
| Sweden | 425 | 89 | 141 | 54 | 710 |
| Scandinavia, excl. Sweden | 675 | 9 | - | 23 | 707 |
| Europe, excl. Scandinavia | 5,363 | 174 | - | 454 | 5,990 |
| U.S. | 13,045 | 687 | - | 308 | 14,040 |
| North America, excl. U.S. | 458 | 27 | - | 61 | 545 |
| South America | 155 | 5 | - | 40 | 201 |
| Africa | 149 | 4 | - | 5 | 158 |
| Australia | 498 | 8 | - | 6 | 512 |
| Asia | 780 | 68 | - | 219 | 1,067 |
| Total | 21,548 | 1,070 | 141 | 1,169 | 23,929 |
| Category | |||||
| Sales of products | 20,654 | 517 | - | 1,155 | 22,326 |
| Sales of services | 858 | 553 | - | 14 | 1,425 |
| Revenues from leasing | 32 | - | 141 | - | 172 |
| Other income | 5 | - | 0 | - | 5 |
| Total | 21,548 | 1,070 | 141 | 1,169 | 23,929 |
| Sales channels | |||||
| Through distributors | 12,208 | 308 | - | 383 | 12,899 |
| Directly to customers | 9,340 | 762 | 141 | 786 | 11,030 |
| Total | 21,548 | 1,070 | 141 | 1,169 | 23,929 |
| Timing of revenue recognition | |||||
| Goods and services transferred | |||||
| at a point of time | 21,318 | 850 | - | 1,169 | 23,337 |
| Goods and services transferred | |||||
| over time | 230 | 221 | 141 | - | 592 |
| Total | 21,548 | 1,070 | 141 | 1,169 | 23,929 |
In the financial statements issued by Investor, Alternative Performance Measures (APMs) are disclosed, which complete measures that are defined or specified in the applicable financial reporting framework, such as revenue, profit or loss or earnings per share.
APMs are disclosed when they complement performance measures defined by IFRS. The basis for disclosed APMs are that they are used by management to evaluate the financial performance and in so believed to give analysts and other stakeholders valuable information.
Investor AB discloses the definitions of all APMs used on http://www.investorab.com/investors-media/investor-infigures/definitions and on pages 153-154 in the Annual Report 2022. Below reconciliations of significant APMs to the most directly reconcilable line item, subtotal or total presented in the financial statements of the corresponding period are disclosed.
Gross cash or Investor's cash and readily available placements are defined as the sum of cash and cash equivalents, short-term investments and interest-bearing current and long-term receivables. Deductions are made for items related to subsidiaries within Patricia Industries.
| Group 6/30 2023, SEK m |
Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's gross cash |
Group 12/31 2022, SEK m |
Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's gross cash |
|---|---|---|---|---|---|---|---|
| Other financial | Other financial | ||||||
| investments | 10,232 | -123 | 10,109 | investments | 9,705 | -116 | 9,590 |
| Cash, bank and short | Cash, bank and short | ||||||
| term investments | 26,174 | -8,793 | 17,382 | term investments | 26,304 | -7,361 | 18,943 |
| Gross cash | 36,407 | -8,916 | 27,491 | Gross cash | 36,009 | -7,476 | 28,533 |
Gross debt is defined as interest-bearing current and long-term liabilities, including pension liabilities, less derivatives with positive value related to the loans. Deductions are made for items related to subsidiaries within Patricia Industries.
| Group 6/30 2023, SEK m |
Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's gross debt |
Group 12/31 2022, SEK m |
Consolidated balance sheet |
Deductions related to Patricia Industries |
Investor's gross debt |
|---|---|---|---|---|---|---|---|
| Receivables included in net debt |
1,149 | -209 | 941 | Receivables included in net debt |
945 | -148 | 797 |
| Loans | -96,091 | 54,544 | -41,547 | Loans | -91,220 | 51,728 | -39,492 |
| Provision for pensions | -807 | 705 | -102 | Provision for pensions | -799 | 699 | -101 |
| Gross debt | -95,749 | 55,040 | -40,708 | Gross debt | -91,074 | 52,278 | -38,796 |
Gross debt less gross cash at Balance Sheet date.
| Group 6/30 2023, SEK m |
Group 12/31 2022, SEK m |
||
|---|---|---|---|
| Investor's gross cash | -27,491 | Investor's gross cash | -28,533 |
| Investor's gross debt | 40,708 | Investor's gross debt | 38,796 |
| Investor's net debt | 13,218 | Investor's net debt | 10,263 |
The net of all assets and liabilities not included in net debt. Total reported assets are based on reported values according to IFRS. Total adjusted assets are adjusted for estimated market values for Patricia Industries' major subsidiaries and partner-owned investments.
| Group 6/30 2023, SEK m |
Consolidated balance sheet |
Deductions related to non controlling interest |
Investor's net asset value |
Group 12/31 2022, SEK m |
Consolidated balance sheet |
Deductions related to non controlling interest |
Investor's net asset value |
|---|---|---|---|---|---|---|---|
| Equity Investor's net debt |
674,817 | -749 | 674,068 13,218 |
Equity Investor's net debt |
605,653 | -788 | 604,865 10,263 |
| Total reported assets |
687,285 | Total reported assets |
615,128 | ||||
| Adjustment for estimated market value Patricia Industries holdings |
98,992 | Adjustment for estimated market value Patricia Industries holdings |
68,385 | ||||
| Total adjusted assets |
786,278 | Total adjusted assets |
683,513 |
Net debt ratio or leverage is defined as Net debt/Net cash as a percentage of total adjusted assets. The target leverange range is 0-10 percent (net debt to total adjusted assets) over a business cycle.
| Group 6/30 2023, SEK m | Net debt ratio | Group 12/31 2022, SEK m | Net debt ratio | ||
|---|---|---|---|---|---|
| Investor's net debt | 13,218 = | Investor's net debt | 10,263 = | ||
| Total adjusted assets | 786,278 | 1.7% | Total adjusted assets | 683,513 | 1.5% |
Reported net asset value is equal to Investor's net asset value and equity attributable to owners of the Parent Company.
Net asset value based on estimated market values for Patricia Industries' major subsidiaries and partner-owned investments. The estimated market values are mainly based on valuation multiples, typically Enterprise value (EV)/Last 12 months' operating profit, for relevant listed peers and indices. More information about the assessment basis can be found in section Patricia Industries - valuation overview on page 8 and Patricia Industries, overview of estimated market values on page 35. In the table below there are a reconciliation between Reported net asset value and Adjusted net asset value. More details regarding the differences can be found in the table Net asset value overview on page 4.
| Group 6/30 2023, SEK m |
Group 12/31 2022, SEK m |
||
|---|---|---|---|
| Reported net asset value | 674,068 | Reported net asset value | 604,865 |
| Reported value for net assets Patricia Industries |
-74,482 | Reported value for net assets Patricia Industries |
-70,110 |
| Estimated market value Patricia Industries holdings |
173,475 | Estimated market value Patricia Industries holdings |
138,495 |
| Adjusted net asset value | 773,060 | Adjusted net asset value | 673,250 |
Equity attributable to shareholders of the Parent Company in relation to the number of shares outstanding at the Balance Sheet date.
| Group 6/30 2023, SEK m | Net asset value, SEK per share |
Group 12/31 2022, SEK m | Net asset value, SEK per share |
||
|---|---|---|---|---|---|
| Investor's reported net asset value | 674,068 | Investor's reported net asset value | 604,865 | ||
| Number of shares, excluding own shares |
= 3,062,525,707 |
220 | Number of shares, excluding own shares |
= 3,063,045,776 |
197 |
Total assets, including estimated market values for Patricia Industries' major subsidiaries and partner-owned investments, less net debt in relation to the number of shares outstanding at the Balance Sheet date.
| Group 6/30 2023, SEK m | Net asset value, SEK per share |
Group 12/31 2022, SEK m | Net asset value, SEK per share |
||
|---|---|---|---|---|---|
| Investor's adjusted net asset value | 773,060 | Investor's adjusted net asset value | 673,250 | ||
| Number of shares, excluding own shares |
= 3,062,525,707 |
252 | Number of shares, excluding own shares |
= 3,063,045,776 |
220 |
| Q2 | Q1 | FY | Q4 | Q3 | Q2 | Q1 | FY | Q4 | Q3 | Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2023 | 2022 | 2022 | 2022 | 2022 | 2022 | 2021 | 2021 | 2021 | 2021 | |
| Mölnlycke (EUR m) Sales |
475 | 479 | 1,828 | 474 | 469 | 459 | 426 | 1,686 | 420 | 405 | 417 |
| Sales growth, % | 4 | 13 | 8 | 13 | 16 | 10 | -4 | -6 | -24 | -15 | 16 |
| Organic growth, | 6 | 13 | 4 | 9 | 9 | 5 | -7 | -6 | -26 | -16 | 18 |
| constant currency, % | |||||||||||
| EBITDA | 135 | 136 | 476 | 105 | 134 | 125 | 112 | 485 | 106 | 112 | 123 |
| EBITDA, % EBITA2) |
28.4 119 |
28.3 120 |
26.1 410 |
22.2 89 |
28.6 118 |
27.2 108 |
26.4 96 |
28.8 421 |
25.1 89 |
27.5 95 |
29.4 107 |
| EBITA, % | 25.0 | 25.0 | 22.4 | 18.7 | 25.1 | 23.6 | 22.6 | 25.0 | 21.2 | 23.4 | 25.6 |
| Operating cash flow | 112 | 54 | 298 | 78 | 119 | 73 | 28 | 382 | 128 | 91 | 84 |
| Net debt | 1,492 | 1,584 | 1,621 | 1,621 | 1,418 | 1,478 | 1,522 | 1,510 | 1,510 | 1,568 | 1,623 |
| Employees | 8,705 | 8,870 | 8,775 | 8,775 | 8,800 | 8,625 | 8,340 | 8,315 | 8,315 | 8,175 | 8,040 |
| Laborie (USD m) | |||||||||||
| Sales | 89 | 84 | 339 | 89 | 85 | 87 | 79 | 313 | 84 | 74 | 80 |
| Sales growth, % | 2 | 7 | 8 | 6 | 15 | 9 | 4 | 36 | 20 | 19 | 85 |
| Organic growth, constant currency, % |
2 | 8 | 12 | 9 | 20 | 9 | 4 | 21 | 14 | 6 | 67 |
| EBITDA | 29 | 25 | 97 | 29 | 26 | 23 | 18 | 93 | 22 | 20 | 28 |
| EBITDA, % | 32.8 | 29.3 | 28.6 | 32.7 | 31.3 | 26.8 | 23.1 | 29.9 | 26.4 | 27.7 | 34.5 |
| EBITA2) | 28 | 23 | 90 | 27 | 25 | 22 | 17 | 83 | 20 | 18 | 25 |
| EBITA, % | 31.1 | 27.5 | 26.7 | 30.6 | 29.5 | 25.0 | 21.0 | 26.6 | 24.2 | 24.4 | 31.3 |
| Operating cash flow | 12 | 23 | 49 | 14 | 20 | 13 | 2 | 60 | 20 | 16 | 22 |
| Net debt | 439 | 444 | 454 | 454 | 461 | 475 | 455 | 424 | 424 | 366 | 396 |
| Employees | 905 | 890 | 895 | 895 | 910 | 885 | 805 | 780 | 780 | 780 | 775 |
| Sarnova (USD m) | |||||||||||
| Sales Sales growth, % |
247 17 |
244 10 |
917 10 |
245 6 |
239 4 |
211 15 |
222 16 |
835 15 |
233 17 |
230 34 |
183 10 |
| Organic growth, | |||||||||||
| constant currency, % | 17 | 10 | 2 | 6 | -5 | 6 | 3 | 0 | 0 | 14 | -3 |
| EBITDA | 40 | 34 | 135 | 41 | 36 | 28 | 30 | 104 | 30 | 24 | 23 |
| EBITDA, % | 16.2 | 13.7 | 14.8 | 16.8 | 14.9 | 13.4 | 13.7 | 12.5 | 13.1 | 10.3 | 12.6 |
| EBITA2) | 35 | 29 | 118 | 37 | 31 | 24 | 26 | 91 | 25 | 21 | 20 |
| EBITA, % Operating cash flow |
14.2 36 |
11.8 42 |
12.9 102 |
15.0 29 |
13.1 15 |
11.5 20 |
11.8 38 |
10.9 77 |
10.9 21 |
9.1 9 |
11.0 24 |
| Net debt | 480 | 496 | 526 | 526 | 541 | 538 | 538 | 569 | 569 | 578 | 496 |
| Employees | 1,405 | 1,425 | 1,435 | 1,435 | 1,355 | 1,360 | 1,375 | 1,370 | 1,370 | 1,370 | 1,240 |
| Permobil (SEK m) | |||||||||||
| Sales | 1,407 | 1,313 | 5,248 | 1,545 | 1,410 | 1,177 | 1,116 | 4,062 | 1,119 | 1,054 | 981 |
| Sales growth, % | 20 | 18 | 29 | 38 | 34 | 20 | 23 | 3 | 10 | 12 | 8 |
| Organic growth, | 13 | 9 | 9 | 17 | 12 | 0 | 6 | 6 | 6 | 11 | 18 |
| constant currency, % EBITDA |
281 | 236 | 1,071 | 389 | 317 | 187 | 177 | 782 | 192 | 211 | 187 |
| EBITDA, % | 20.0 | 18.0 | 20.4 | 25.1 | 22.5 | 15.9 | 15.9 | 19.2 | 17.2 | 20.1 | 19.0 |
| EBITA2) | 230 | 185 | 880 | 335 | 266 | 145 | 133 | 612 | 149 | 168 | 147 |
| EBITA, % | 16.3 | 14.1 | 16.8 | 21.7 | 18.9 | 12.3 | 12.0 | 15.1 | 13.3 | 16.0 | 15.0 |
| Operating cash flow | 201 | 178 | 435 | 252 | 182 | 13 | -13 | 214 | 37 | 90 | -12 |
| Net debt | 3,735 | 3,610 | 3,330 | 3,330 | 3,752 | 3,568 | 3,388 | 3,166 | 3,166 | 3,026 | 2,959 |
| Employees | 1,830 | 1,805 | 1,805 | 1,805 | 1,780 | 1,755 | 1,755 | 1,660 | 1,660 | 1,645 | 1,630 |
| Advanced Instruments (USD m) | |||||||||||
| Sales | 37 | 34 | 134 | 35 | 35 | 33 | 31 | 103 | 31 | 26 | 24 |
| Sales growth, % Organic growth, |
12 | 8 | 31 | 13 | 33 | 41 | 44 | 34 | 45 | 33 | 49 |
| constant currency, % | -1 | -9 | 7 | -5 | 3 | 16 | 20 | 24 | 18 | 26 | 47 |
| EBITDA | 16 | 12 | 45 | 11 | 12 | 8 | 14 | 38 | 12 | 3 | 12 |
| EBITDA, % | 42.7 | 36.0 | 33.6 | 32.1 | 35.9 | 22.7 | 44.3 | 37.1 | 37.1 | 13.3 | 50.9 |
| EBITA2) | 15 | 11 | 43 | 11 | 12 | 7 | 13 | 37 | 11 | 3 | 12 |
| EBITA, % | 40.7 | 34.0 | 32.1 | 30.6 | 34.3 | 21.3 | 42.8 | 35.7 | 35.8 | 11.9 | 49.5 |
| Operating cash flow Net debt |
16 229 |
7 237 |
35 206 |
7 206 |
16 206 |
8 208 |
5 192 |
32 195 |
10 195 |
7 203 |
9 142 |
| Employees | 325 | 355 | 370 | 370 | 370 | 350 | 225 | 225 | 225 | 225 | 145 |
| Piab (SEK m) | |||||||||||
| Sales | 789 | 720 | 2,450 | 661 | 620 | 619 | 551 | 1,738 | 472 | 438 | 422 |
| Sales growth, % | 27 | 31 | 41 | 40 | 42 | 47 | 36 | 14 | 8 | 25 | 23 |
| Organic growth, | 4 | 12 | 11 | 7 | 6 | 17 | 17 | 18 | 8 | 26 | 33 |
| constant currency, % | |||||||||||
| EBITDA EBITDA, % |
222 28.2 |
205 28.5 |
619 25.2 |
122 18.4 |
163 26.2 |
173 27.9 |
161 29.3 |
485 27.9 |
109 23.1 |
130 29.6 |
126 29.8 |
| EBITA2) | 193 | 181 | 530 | 97 | 139 | 152 | 142 | 409 | 81 | 113 | 110 |
| EBITA, % | 24.5 | 25.1 | 21.6 | 14.7 | 22.4 | 24.5 | 25.9 | 23.5 | 17.2 | 25.9 | 26.0 |
| Operating cash flow | 199 | 114 | 411 | 113 | 138 | 102 | 58 | 376 | 79 | 106 | 104 |
| Net debt | 3,097 | 2,952 | 2,431 | 2,431 | 2,591 | 2,423 | 1,986 | 1,767 | 1,767 | 1,505 | 1,548 |
| Employees | 1,185 | 1,160 | 1,030 | 1,030 | 1,020 | 995 | 875 | 695 | 695 | 680 | 660 |
INVESTOR Q2 2023 – 33
| Q2 | Q1 | FY | Q4 | Q3 | Q2 | Q1 | FY | Q4 | Q3 | Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2023 | 2022 | 2022 | 2022 | 2022 | 2022 | 2021 | 2021 | 2021 | 2021 | |
| BraunAbility (USD m) | |||||||||||
| Sales | 288 | 250 | 929 | 242 | 252 | 211 | 224 | 692 | 184 | 192 | 171 |
| Sales growth, % | 36 | 12 | 34 | 32 | 31 | 24 | 53 | 22 | 22 | 26 | 86 |
| Organic growth, | 36 | 11 | 28 | 25 | 28 | 19 | 43 | 17 | 14 | 17 | 81 |
| constant currency, % | |||||||||||
| EBITDA | 37 | 33 | 86 | 24 | 23 | 17 | 22 | 52 | 13 | 17 | 12 |
| EBITDA, % | 12.9 | 13.1 | 9.3 | 9.9 | 9.3 | 8.1 | 9.8 | 7.5 | 7.2 | 9.0 | 7.1 |
| EBITA2) | 32 | 28 | 67 | 19 | 19 | 13 | 17 | 35 | 9 | 13 | 8 |
| EBITA, % | 11.1 | 11.1 | 7.2 | 7.7 | 7.5 | 5.9 | 7.7 | 5.1 | 4.6 | 6.6 | 4.9 |
| Operating cash flow | 24 | 0 | 46 | 14 | 19 | 3 | 9 | 38 | 8 | 23 | 6 |
| Net debt | 277 | 290 | 284 | 284 | 288 | 302 | 302 | 300 | 300 | 307 | 326 |
| Employees | 2,035 | 1,990 | 1,945 | 1,945 | 1,995 | 1,890 | 1,850 | 1,825 | 1,825 | 1,825 | 1,760 |
| Vectura (SEK m) Sales |
82 | 84 | 302 | 78 | 74 | 75 | 74 | 279 | 71 | 61 | 66 |
| Sales growth, % | 9 | 13 | 8 | 9 | 23 | 14 | -8 | -6 | -20 | -21 | -3 |
| EBITDA | 41 | 55 | 178 | 42 | 45 | 47 | 44 | 172 | 42 | 40 | 41 |
| EBITDA, % | 49.5 | 65.9 | 58.9 | 53.9 | 60.4 | 62.0 | 59.6 | 61.5 | 59.2 | 66.2 | 62.1 |
| EBITA adjusted2) | 4 | 23 | 50 | 10 | 13 | 15 | 13 | 45 | 7 | 13 | 13 |
| EBITA, % | 4.7 | 27.7 | 16.7 | 12.5 | 17.0 | 20.1 | 17.3 | 16.0 | 9.5 | 21.7 | 19.8 |
| Operating cash flow | -347 | -351 | -614 | -160 | -76 | -252 | -126 | -355 | -97 | -52 | -160 |
| Net debt | 5,901 | 5,679 | 5,223 | 5,223 | 4,984 | 4,376 | 4,343 | 3,963 | 3,963 | 3,453 | 2,537 |
| Real estate, | |||||||||||
| market value | 10,276 | 9,650 | 8,388 | ||||||||
| Employees | 50 | 50 | 49 | 49 | 44 | 41 | 38 | 33 | 33 | 31 | 31 |
| Atlas Antibodies (SEK m) | |||||||||||
| Sales | 108 | 110 | 398 | 98 | 100 | 104 | 95 | 324 | 81 | 86 | 81 |
| Sales growth, % | 4 | 16 | 23 | 21 | 16 | 29 | 26 | 31 | 23 | 38 | 43 |
| Organic growth, | -6 | 7 | 14 | 9 | 7 | 21 | 20 | 34 | 19 | 39 | 47 |
| constant currency, % EBITDA |
43 | 53 | 187 | 42 | 52 | 48 | 45 | 162 | 42 | 45 | 36 |
| EBITDA, % | 40.0 | 48.4 | 47.0 | 42.8 | 52.3 | 45.7 | 47.4 | 50.1 | 51.4 | 52.3 | 43.9 |
| EBITA2) | 36 | 46 | 165 | 36 | 46 | 42 | 40 | 143 | 37 | 40 | 31 |
| EBITA, % | 32.9 | 41.7 | 41.4 | 37.0 | 46.4 | 40.4 | 41.9 | 44.2 | 45.0 | 46.5 | 38.1 |
| Operating cash flow | 36 | 28 | 94 | 17 | 45 | 18 | 14 | 115 | 24 | 56 | 13 |
| Net debt | 338 | 372 | 342 | 342 | 352 | 391 | 403 | 406 | 406 | 429 | 22 |
| Employees | 120 | 120 | 130 | 130 | 120 | 120 | 120 | 115 | 115 | 110 | 115 |
| Three Scandinavia | |||||||||||
| Sales, SEK m | 3,004 | 3,021 | 11,834 | 3,283 | 3,025 | 2,798 | 2,728 | 10,750 | 2,925 | 2,696 | 2,543 |
| Sweden, SEK m | 1,908 | 1,911 | 7,668 | 2,160 | 1,942 | 1,817 | 1,749 | 6,946 | 1,929 | 1,740 | 1,617 |
| Denmark, DKK m | 708 | 744 | 2,904 | 756 | 755 | 700 | 694 | 2,787 | 730 | 697 | 676 |
| EBITDA, SEK m | 989 | 868 | 3,729 | 973 | 948 | 917 | 891 | 3,535 | 931 | 892 | 849 |
| Sweden, SEK m | 716 | 666 | 2,732 | 706 | 695 | 675 | 656 | 2,564 | 636 | 662 | 625 |
| Denmark, DKK m | 177 | 136 | 694 | 180 | 176 | 172 | 167 | 711 | 216 | 168 | 164 |
| EBITDA, % | 32.9 | 28.7 | 31.5 | 29.7 | 31.3 | 32.8 | 32.7 | 32.9 | 31.8 | 33.1 | 33.4 |
| Sweden | 37.5 | 34.8 | 35.6 | 32.7 | 35.8 | 37.2 | 37.5 | 36.9 | 33.0 | 38.1 | 38.6 |
| Denmark | 24.9 | 18.3 | 23.9 | 23.8 | 23.3 | 24.6 | 24.0 | 25.5 | 29.6 | 24.1 | 24.2 |
| Net debt, SEK m | 7,491 | 7,323 | 7,294 | 7,294 | 6,969 | 6,731 | 6,406 | 6,498 | 6,498 | 5,940 | 6,070 |
| Employees | 1,790 | 1,800 | 1,790 | 1,790 | 1,765 | 1,715 | 1,735 | 1,735 | 1,735 | 1,685 | 1,775 |
1) For information regarding Alternative Performance Measures in the table, see page 18. Definitions can be found on Investor's website.
2) EBITA is defined as operating profit before acquisition-related amortizations.
| Valuation methodology | |
|---|---|
| Listed Companies | Share price (bid) for the class of shares held by Investor, with the exception of Saab, Electrolux and Electrolux Professional for which the most actively traded share class is used. Ownership calculated in accordance with the disclosure of regulations of Sweden's Financial Instruments Trading Act (LHF). ABB, Accelleron, AstraZeneca, Nasdaq and Wärtsilä in accordance with Swiss, British, U.S. and Finnish regulations. Includes market value of derivatives related to investments if applicable. |
| Patricia Industries | |
| Subsidiaries | Reported value based on the acquisition method. As supplementary information, subsidiaries are also presented at estimated market values, mainly based on valuation multiples for relevant listed peers and indices. Other methodologies may also be used, for example relating to real estate assets. New investments valued at invested amount during the first 18 months following the acquisition. |
| Partner-owned investments | Reported value based on the equity method. As supplementary information, partner-owned investments are also presented at estimated market values, mainly based on valuation multiples for relevant listed peers and indices. |
| Financial Investments | Unlisted holdings at multiple or third-party valuation, listed shares at share price (bid). |
| Investments in EQT | Unlisted holdings at multiple or third-party valuation, listed shares at share price (bid). |
| Supplementary information | In addition to reported values, which are in accordance with IFRS, Investor provides estimated market values for the wholly-owned subsidiaries and partner-owned investments within Patricia Industries in order to facilitate the evaluation of Investor's net asset value. This supplementary, non-GAAP information also increases the consistency between the valuation of Listed Companies and our major wholly-owned subsidiaries and partner-owned Three Scandinavia. |
|---|---|
| Estimated market values | While the estimated market values might not necessarily reflect our view of the intrinsic values, they reflect how the stock market values similar companies. |
| Methodology | The estimated market values are mainly based on valuation multiples (median), typically Enterprise value (EV)/Last 12 months' operating profit, for relevant listed peers and indices. We define EV as quarterly volume-weighted average share price (VWAP) plus closing date net debt. While we focus on EBITA when evaluating the performance of our companies, for valuation purposes, EBITDA multiples are more commonly available, and therefore often used. From the estimated EV, net debt is deducted, and the remaining equity value is multiplied with Patricia Industries' share of capital. |
| Adjustments | Operating profit is adjusted to reflect, for example, pro forma effects of completed add-on acquisitions and certain non-recurring items. An item is only viewed as non-recurring if it exceeds a certain amount set for each company, is unlikely to affect the company again, and does not result in any future benefit or cost. Acquisitions made less than 18 months ago are valued at cost. |
Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective. Through board representation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class. Our holdings include, among others, ABB, Atlas Copco, Ericsson, Mölnlycke and SEB.
We create value for people and society by building strong and sustainable businesses.
Our ultimate target is to generate an attractive total return. Our long-term return requirement is the risk free interest rate plus an equity risk premium, in total 8-9 percent annually.
We own high-quality companies and are an engaged owner, supporting our companies to achieve profitable growth. We strive to allocate our capital wisely.
Our goal is to pay a steadily rising dividend. Our dividend policy is supported by cash flow from all three business areas: Listed Companies, Patricia Industries and Investments in EQT.
We firmly believe that sustainability integrated in the business model is a prerequisite for creating long-term value. Our three focus areas with specific targets are Business Ethics & Governance, Climate & Resource Efficiency and Diversity & Inclusion.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.